1. Cancer Biology
  2. Cell Biology
Download icon

Mitosis can drive cell cannibalism through entosis

  1. Joanne Durgan
  2. Yun-Yu Tseng
  3. Jens C Hamann
  4. Marie-Charlotte Domart
  5. Lucy Collinson
  6. Alan Hall
  7. Michael Overholtzer
  8. Oliver Florey Is a corresponding author
  1. The Babraham Institute, United Kingdom
  2. Memorial Sloan Kettering Cancer Center, United States
  3. Cornell University, United States
  4. Louis V Gerstner Jr Graduate School of Biomedical Sciences, United States
  5. The Francis Crick Institute, United Kingdom
Research Article
Cited
1
Views
3,591
Comments
0
Cite as: eLife 2017;6:e27134 doi: 10.7554/eLife.27134

Abstract

Entosis is a form of epithelial cell cannibalism that is prevalent in human cancer, typically triggered by loss of matrix adhesion. Here, we report an alternative mechanism for entosis in human epithelial cells, driven by mitosis. Mitotic entosis is regulated by Cdc42, which controls mitotic morphology. Cdc42 depletion enhances mitotic deadhesion and rounding, and these biophysical changes, which depend on RhoA activation and are phenocopied by Rap1 inhibition, permit subsequent entosis. Mitotic entosis occurs constitutively in some human cancer cell lines and mitotic index correlates with cell cannibalism in primary human breast tumours. Adherent, wild-type cells can act efficiently as entotic hosts, suggesting that normal epithelia may engulf and kill aberrantly dividing neighbours. Finally, we report that Paclitaxel/taxol promotes mitotic rounding and subsequent entosis, revealing an unconventional activity of this drug. Together, our data uncover an intriguing link between cell division and cannibalism, of significance to both cancer and chemotherapy.

https://doi.org/10.7554/eLife.27134.001

eLife digest

For over a century, scientists looking down microscopes at samples from human cancers have noticed cells eating other cells – in other words, cell cannibalism. The causes and mechanisms involved in this unusual process, which is also known as entosis, are not well understood and its relationship to cancer is complex. On one hand, cell cannibalism may promote cancer by providing nutrients for growing tumours and making it more likely that genetic errors will occur. On the other hand, this process may resist cancer by eliminating damaged cells.

In the laboratory, cell cannibalism has only been seen in cells that are detached from their surroundings. Cells in the body are typically surrounded and supported by a mesh of proteins called the extracellular matrix. However, within a tumour, cancer cells can often begin to grow without being attached to the matrix, which means that cell cannibalism can occur. A protein called Cdc42 plays a part in how cells attach to each other and to the extracellular matrix, but the role of Cdc42 in controlling entosis had not been previously explored.

Durgan et al. initially set out to ask whether Cdc42 was involved in the established process of cell cannibalism, as seen in detached cells. However, the experiments showed that removing Cdc42 from human cells grown in the laboratory had little effect on this method of entosis. Unexpectedly, though, the loss of Cdc42 did enable a different form of cell cannibalism in cells that remained attached to the extracellular matrix, which had not been seen before. This new cannibalism process is linked to cell division, with cells that are dividing or that have recently divided being consumed by neighbours. This form of cell cannibalism is more commonly seen in cancers where the cells divide a lot, and some chemotherapy drugs that interfere with cell division also increase the rate of cell cannibalism.

During cell division a group of proteins – including RhoA and myosin – cause cells to become rounder and stiffer. Durgan et al. suggest this allows the dividing cells to force their way inside other cells, the key first stage of entosis. Since cancer cells divide often, this form of cell cannibalism may lead to the cancer cells being destroyed by their healthy neighbours, in a form of “assisted suicide”. This reveals an unexpected link between cell division and cell cannibalism, which is relevant to both cancer and chemotherapy. Future work will explore whether entosis can be used to predict how a cancer will progress in a patient, or how they will respond to a given treatment.

https://doi.org/10.7554/eLife.27134.002

Introduction

Cellular cannibalism is an ancient form of feeding used by bacteria (González-Pastor et al., 2003) and predatory amoebae (Waddell and Duffy, 1986) in response to starvation. A similar phenomenon is observed among epithelial cells in human cancer (Brouwer et al., 1984; Overholtzer et al., 2007; Overholtzer and Brugge, 2008; Sharma and Dey, 2011; Yang and Li, 2012; Cano et al., 2012), suggesting this primeval process may promote survival within the tumour microenvironment (Fais, 2007; Matarrese et al., 2008; He et al., 2013; Lozupone and Fais, 2015). Homotypic epithelial cell cannibalism can occur by entosis, an intriguing process through which one live and viable cell is completely engulfed by another, yielding a ‘cell-in-cell’ structure (Overholtzer et al., 2007). The vast majority of internalised, entotic cells are ultimately killed and digested by their hosts, through a mechanism involving non-canonical autophagy and lysosomal degradation (Yuan and Kroemer, 2010; Florey et al., 2011).

Entosis is observed in a wide range of human cancers (Overholtzer et al., 2007; Overholtzer and Brugge, 2008) and is believed to mediate pleiotropic effects on cancer biology. On one hand, entotic cell killing can limit outgrowth through the elimination of internalised cells (Florey et al., 2011), representing a possible means of tumour suppression. Conversely, entosis simultaneously promotes host cell survival and transformation, by providing valuable nutrients (Fais, 2007; Krajcovic et al., 2013) and driving genomic instability (Krajcovic et al., 2011). Consistent with these pro-tumorigenic effects, the frequency of entosis is found to increase with tumour grade (Krajcovic et al., 2011), and cell-in-cell formation correlates with poor patient outcome (Schwegler et al., 2015; Schenker et al., 2017), suggesting this process may be associated with tumour progression. Finally, entosis can mediate cancer cell competition (Sun et al., 2014a), allowing one population to preferentially engulf and kill another, and may therefore contribute to shaping tumour evolution. Together, these findings indicate that entosis can mediate both tumour suppressive and promoting effects (Krishna and Overholtzer, 2016), but the overall impact of entotic cell cannibalism on tumour biology and progression remains to be fully understood (Durgan and Florey, 2015).

Mechanistically, entosis involves the formation of adherens junctions and the generation of actomyosin-based contractility, which enables one cell to actively push or ‘invade’ into a more deformable neighbour, in an unconventional mode of engulfment (Overholtzer et al., 2007). This process is known to be triggered by matrix deadhesion, which renders the cells unanchored and this contractile force unopposed. ROCK-mediated myosin phosphorylation is indispensable for entosis in cultured cells (Overholtzer et al., 2007; Sun et al., 2014a; Wan et al., 2012; Sun et al., 2014b) and during embryonic implantation (Li et al., 2015). Accordingly, regulated changes in actomyosin contractility, as induced by oncogenic K-Ras, can modulate entosis in suspension (Sun et al., 2014a); a similar mechanism operates during the early stages of matrix adhesion (Wan et al., 2012).

Rho-family small GTPases regulate many fundamental cellular processes (Jaffe and Hall, 2005; Heasman and Ridley, 2008), including entosis. RhoA controls actomyosin contractility through ROCK, and blebbing through mDia, and is therefore indispensable for cell-in-cell formation (Overholtzer et al., 2007; Yamada and Nelson, 2007; Purvanov et al., 2014). Similarly, Rac1 can regulate myosin phosphorylation to modulate entotic cell competition (Sun et al., 2014a). Other Rho-family members seem likely to influence cell cannibalism, through effects on the actomyosin cytoskeleton, cell-cell contacts or cell-matrix adhesion, but their contributions have yet to be investigated. The present study was initiated to explore a possible role for Cdc42, a master regulator of epithelial cell biology (Heasman and Ridley, 2008; Joberty et al., 2000; Etienne-Manneville, 2004; Martin-Belmonte et al., 2007; Jaffe et al., 2008; Wallace et al., 2010; Roignot et al., 2013). Unexpectedly, this work has uncovered a novel mechanism of entotic cell-in-cell formation, driven by mitosis. We present our findings on the relationship between epithelial cell division and cannibalism and demonstrate its relevance to both human cancer and chemotherapy.

Results

Cdc42 controls cell-in-cell formation in adherent epithelial cells

To assess a possible role in entosis, Cdc42 was depleted in 16HBE human bronchial epithelial cells, using multiple distinct and non-overlapping RNAi reagents. All Cdc42-specific duplexes and hairpins yield a robust knockdown (Figure 1a), and induce expected functional changes, such as disruption of adherens (AJ) and tight junction (TJ) maturation (Figure 1b) (Wallace et al., 2010). To initiate entosis, cells were cultured in suspension for 8 hr (Figure 1c–d), inducing cell-in-cell formation among ~10% of control cells, consistent with previous reports (Krajcovic et al., 2011). Surprisingly, despite clear effects on AJ maturation, Cdc42 depletion has no major impact on cell-in-cell formation under these conditions, suggesting that primordial junctions are sufficient to support entosis. Strikingly, however, we found instead that Cdc42 depletion promotes robust cell-in-cell formation in adherent culture (Figure 1e–f), in which entosis would not be expected to occur. This surprising phenotype is reproducible and statistically significant across all RNAi reagents tested, corresponding closely with knockdown efficiency (compare siCdc42.1/2), consistent with a specific, on-target effect of Cdc42. Furthermore, adherent cell-in-cell formation is also observed in Cdc42-depleted MCF7 breast epithelia (Figure 1g–i), indicating that this process is consistent across multiple cell lines, derived from different tissues of origin. Together, these data reveal that Cdc42 does not play a significant role in conventional entosis, but unexpectedly controls a novel form of cell-in-cell formation among adherent cells.

Cdc42 controls entosis in adherent epithelial cells.

(a) Control and siRNA or shRNA Cdc42-depleted 16HBE cell lysates were probed for Cdc42 and GAPDH expression by western blotting. (b) Representative confocal images of control and Cdc42-depleted 16HBE monolayers stained for β-catenin (adherens junctions), ZO-1 (tight junctions) and DNA. Scale bar = 20 μm. (c) Representative images of cell-in-cell structures formed in matrix detached control and Cdc42-depleted 16HBE cells. Cell were stained for DNA (blue) and imaged by IF/confocal and DIC. Scale bar = 5 μm. (d) Quantification of suspension cell-in-cell formation in control and Cdc42-depleted cells. >200 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. ns = no significant difference, t-test. (e) Representative images of a cell-in-cell structure formed under adherent conditions in Cdc42-depleted 16HBE cells. Cells were stained for cell body (green) and DNA (blue) and imaged by IF/confocal and DIC. Scale bar = 10 μm. (f) Quantification of adherent cell-in-cell formation. >200 16HBE cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. **p<0.002; ***p<0.0002; ****p<0.0001, t-test. (g) Control and shRNA Cdc42-depleted MCF7 cell lysates were probed for Cdc42 and GAPDH expression by western blotting. (h) Representative images of a cell-in-cell structure formed under adherent conditions in Cdc42-depleted MCF7 cells. Cells were stained for cell body (green) and DNA (blue) and imaged by IF/confocal and DIC. Scale bar = 10 μm. (i) Quantification of adherent cell-in-cell formation. >200 MCF7 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. *p<0.02, t-test. (j) Lysates from 16HBE cells co-depleted of Cdc42 and α-catenin (aCat) were probed for α-catenin, Cdc42 and GAPDH by western blotting. (k) Representative confocal images of 16HBE cells co-depleted of Cdc42 and siControl or α-catenin and stained for β-catenin (green) and DNA (blue). Scale bar = 20 μm. (l) Quantification of cell-in-cell structures in adherent 16HBE cells treated with siCdc42 and siControl or siα-catenin, treated −/+10 μM Y-27632 (ROCKi), for 3 days. >200 cells were scored per sample/experiment, across three separate experiments. Error bars denote mean±SEM. **p<0.002; ***p<0.0002, t-test. (m) Confocal images of a forming cell-in-cell structure in adherent, Cdc42-depleted 16HBE cells fixed and costained for pMLC2 (S19; green), β-catenin (red) and DNA (Hoechst, blue). The arrowhead indicates the tail of the internalising cell. Scale bar = 10 μm. (n) Cell-in-cell structures in Cdc42-depleted 16HBE cells were fixed and costained for LC3 (green), LAMP1 (red) and DNA (blue), and imaged by IF/confocal and DIC. The arrowhead indicates a dying internalised cell. Scale bar = 10 μm.

https://doi.org/10.7554/eLife.27134.003

Adherent cell-in-cell formation shares the mechanistic features of entosis

The adherent cell-in-cell structures observed upon Cdc42 depletion morphologically resemble those formed through entosis. However, entosis is typically triggered by matrix detachment, occuring in suspension (Overholtzer et al., 2007), or during the early stages of adhesion (6–8 hr after plating) (Wan et al., 2012). To determine whether adherent cell-in-cell formation otherwise bears the hallmarks of entosis, additional characteristics were analysed. Firstly, Cdc42 was co-depleted with α-catenin, a core junctional component that is indispensible for entosis (Wang et al., 2015) (Figure 1j–l). α-catenin depletion yields profound AJ defects, and a corresponding reduction in cell-in-cell formation, in line with an entotic mechanism. Next, the involvement of actomyosin contractility was assessed, which drives suspension entosis downstream of RhoA/ROCK (Overholtzer et al., 2007). Inhibition of ROCK dramatically suppresses cell-in-cell formation among Cdc42-depleted cells (Figure 1l), like entosis under detached (Overholtzer et al., 2007; Sun et al., 2014a, 2014b), semi-adherent (Wan et al., 2012) or in vivo conditions (Li et al., 2015). Consistent with this, active, phospho-myosin (pS10-MLC2) is clearly enriched in the internalising cell tail (Figure 1m). Finally, entotic cell cannibalism characteristically involves non-canonical autophagy (Florey et al., 2011) and lysosomal degradation (Overholtzer et al., 2007; Krajcovic et al., 2013). Consistent with this mechanism, both LC3 (an autophagy protein) and LAMP1 (a lysosomal marker) are transiently recruited to the vacuoles of Cdc42-depleted cell-in-cell structures (Figure 1n). Taken together, these data reveal that entosis can indeed occur among adherent epithelial cells and suggest that a distinct mechanism must trigger cell-in-cell formation under these conditions.

Mitosis drives entosis in adherent cells

To investigate the mechanism underlying adherent entosis, long-term timelapse imaging was used to track live cell-in-cell formation events among Cdc42-depleted cells. Representative movies and stills are shown (Figure 2a–c, Videos 13). During every cell-in-cell event analysed, the inner cell penetrates its host either during, or shortly after, mitosis. Several permutations of this process were observed, with one or both daughters penetrating the same or different hosts, or one daughter invading the other and both entering an adherent neighbour (cell-in-cell-in-cell). To support these studies, fixed, adherent, entotic events were visualised at a mid-way point by IF/3D-correlative light-electron microscopy (CLEM; Figure 2d, Videos 45). In each case, mitotic cells were observed internalising into adherent neighbours. These comprehensive imaging studies establish a clear relationship between cell division and cell-in-cell formation, suggesting that mitosis may drive entosis in adherent cell populations. To test this model more directly, Cdc42-depleted cells were arrested at the G2/M boundary using a Cdk1 inhibitor (RO-3306). Strikingly, inhibition of mitosis leads to a profound decrease in cell-in-cell formation in matrix-attached, but not detached conditions (Figure 2e). These data indicate that cell division drives adherent, but not suspension, entosis, highlighting two mechanistically distinct routes to epithelial cell cannibalism.

Mitosis drives entotic cell cannibalism in adherent cells.

(a–c) Cdc42-depleted 16HBE cells were analysed by timelapse microscopy. Three different configurations of cell-in-cell formation are shown with timestamps (hr:min). In each case, a mitotic cell (Cell 1, outlined white) enters an adherent entotic host (Cell 2, outlined yellow). Scale bars = 10 μm. (d) Cdc42-depleted 16HBE cells were analysed by 3D-CLEM. (i) Live confocal sections from basal and mid-planes of a forming cell-in-cell structure, stained for plasma membrane (red), cell body (green) and DNA (blue). A mitotic daughter (Cell 1) is shown internalising into an adherent neighbour (Cell 2). Scale bar = 10 μm. (ii) Corresponding serial blockface scanning electron microscopy (SBF-SEM) images of the same forming structure. The arrowhead marks the midbody between daughter cells. (iii) Cartoon outline of cell-in-cell structure from (ii). (e) Quantification of cell-in-cell formation among control and Cdc42-depleted 16HBE cells, under adherent or suspension conditions, in the presence or absence of RO-3306 (5 μM), a Cdk1 inhibitor that induces G2/M arrest. >200 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. **p<0.002; ns = no significant difference, t-test. (f) Representative confocal and DIC images of adherent cell-in-cell structures in wild-type-16HBE (red) and Cdc42-depleted GFP-16HBE (green) co-cultures. Scale bar = 15 μm. (g) Quantification of cell-in-cell formation between WT and Cdc42-depleted 16HBE co-cultures as described in (f). >50 cell-in-cell structures were imaged per condition/experiment, across three separate experiments. Error bars denote mean±SEM. (h) Cdc42-depleted 16HBE cells were mixed with wild-type cells expressing RFP-zyxin, incubated for 3 days then stained for plasma membrane (green) and DNA (blue) and imaged by live confocal and DIC microscopy. A representative adherent cell-in-cell structure is shown, with basal and mid-plane sections presented; asterix = host cell nucleus, arrowhead = internalised cell. Scale bar = 15 μm. (i) Inner cell fate was analysed in Cdc42-depleted adherent 16HBE entotic structures, stained for DNA (blue). Representative timelapse series show non-apoptotic and apoptotic inner cell death; timestamps = (hr:min). Scale bar = 10 μm. (j) Quantification of inner cell fate over 20 hr in adherent Cdc42-depleted 16HBE structures. 154 cell-in-cell structures were analysed over three independent experiments.

https://doi.org/10.7554/eLife.27134.005
Video 1
Mitosis-driven entosis in adherent Cdc42-depleted 16HBE cells.

DIC images from Widefield timelapse. Cell 1 engulfed by cell 2 post mitosis.

https://doi.org/10.7554/eLife.27134.007
Video 2
Mitosis-driven entosis in adherent Cdc42-depleted 16HBE cells.

DIC images from Widefield timelapse. Cell 1 is engulfed by cell 2 during mitosis.

https://doi.org/10.7554/eLife.27134.008
Video 3
Mitosis-driven entosis in adherent Cdc42-depleted 16HBE cells.

DIC images from Widefield timelapse. Cell 1 daughters engulf each other and are then engulfed by cell 2.

https://doi.org/10.7554/eLife.27134.009
Video 4
Live cell confocal z-stack of a forming cell-in-cell structure in Cdc42-depleted adherent 16HBE cells.

Cells are stained with CellTracker green (cell body), CellMASK, red (membrane) and Hoechst (DNA, blue).

https://doi.org/10.7554/eLife.27134.010
Video 5
Corresponding Serial Block Face SEM z-stack of forming cell-in-cell structure in Video 4.
https://doi.org/10.7554/eLife.27134.011

Dividing cells can be cannibalised by fully adherent, wild-type neighbours

To investigate the process of mitosis-induced entosis further, we examined the role of Cdc42 more closely, testing whether its depletion affects the internalising mitotic cell, or its host. Control and Cdc42-depleted cells were labelled red or green, respectively, and then reseeded to yield an equally mixed monolayer. Inner/outer cell identities were scored among the adherent, cell-in-cell structures formed (Figure 2f–g). In almost all pairs, the inner cell is Cdc42-depleted. These cells penetrate control or knockdown neighbours with equal frequency, and the results are unchanged by dye reversal (data not shown). These findings establish that loss of Cdc42 specifically promotes internalisation, enabling a dividing cell to ‘invade’ into an adherent neighbour, while having no detectable effect on the host. Given that wild-type cells act efficiently as hosts, we can exclude the possibility that Cdc42-depletion promotes entosis by impairing cell-matrix contacts to ‘mimic’ deadhesion. To verify this further, Cdc42-depleted cells were mixed with wild-type cells expressing RFP-zyxin, an adhesome component (Horton et al., 2015). Basal RFP-zyxin-positive foci are observed within entotic hosts (Figure 2h), reinforcing the conclusion that the host cell can be fully matrix-adhered. Finally, we analysed the consequences of mitosis-induced entosis under adherent conditions. Cdc42-depleted 16HBE cell-in-cell structures were followed by timelapse microscopy and the fate of the internalised cell recorded (Figure 2i–j). As in suspension conditions (Overholtzer et al., 2007; Florey et al., 2011), the majority of internalised cells die, by either non-apoptotic or apoptotic means, within the entotic vacuole, establishing mitotic entosis in adherent cells as a means of epithelial cell cannibalism. Together, our data demonstrate that loss of Cdc42 permits a dividing cell to ‘invade’ into a neighbour by entosis, and clarify that the host cell can be wild-type and fully adherent. These findings raise the intriguing concept that normal, adherent epithelia may engulf, kill and digest dividing neighbours under certain conditions.

Cdc42 controls mitotic morphology in polarised epithelia

Our findings support a model in which epithelial Cdc42 inhibits entosis among mitotic cells. To investigate the possible mitotic functions of Cdc42, dividing cells were analysed by flow cytometry and microscopy. No gross defects in cell cycle progression are detected upon Cdc42-depletion by flow cytometric analysis of DNA content (Figure 3a). However, imaging studies reveal significant morphological changes during cell division. Control and Cdc42-depleted cells were visualised during the different phases of mitosis, in live cells stained for plasma membrane and DNA (Figure 3b). Consistent with previous reports, we observed that Cdc42-depletion can misorient the plane of division (Jaffe et al., 2008; Roignot et al., 2013), while control cells divide parallel to the substrate, the plane of division in Cdc42-depleted cells is randomised. However, this phenotype seems unlikely to drive cell-in-cell formation, as aPKC-depletion promotes similar spindle misorientation (Durgan et al., 2011), with no detectable effect on entosis under these conditions (Figure 3—figure supplement 1). Interestingly, we also identified additional, unanticipated changes in mitotic morphology upon Cdc42-depletion (Figure 3b–d). Like other polarised epithelia (Reinsch and Karsenti, 1994), WT-16HBE cells bulge as they enter prometaphase, but retain both cell-cell and cell-matrix contacts throughout mitosis (Figure 3b, upper panel). In contrast, from prometaphase onwards, Cdc42-depleted cells exhibit reduced spreading, associated with a diminished adhesive surface area, and dramatic rounding, a closely related phenomenon (Marchesi et al., 2014) (Figure 3b, lower panel). These morphological changes can be quantified by calculating height/length, as a measure of cell spreading (Figure 3c), and circularity, as a score of roundness (Figure 3d). Across multiple reagents and experiments, Cdc42-depletion consistently and significantly augments mitotic deadhesion and rounding. These data uncover a novel role for Cdc42 in controlling mitotic morphology in polarised epithelial cells.

Figure 3 with 1 supplement see all
Cdc42 controls mitotic deadhesion and rounding in polarised epithelial cells.

(a) Control and Cdc42-depleted 16HBE cells were fixed and stained with propidium iodide. DNA content was analysed by FACS. (b) Control and Cdc42-depleted 16HBE cells were stained for plasma membrane (red) and DNA (blue), and analysed by live confocal microscopy. Representative sections and z-stacks of different phases of mitosis are shown. Scale bar = 20 μm. Quantification of (c) mitotic spreading (cell height/length) and (d) mitotic rounding (where 1 = a perfect circle) in control and Cdc42-depleted cells. >10 metaphase cells were imaged per sample/experiment, across three independent experiments. Error bars denote mean±SD. ****p<0.0001, Mann-Whitney U test.

https://doi.org/10.7554/eLife.27134.012

Cdc42 regulates cortical RhoA activity in mitotic cells

We next considered the molecular mechanisms through which Cdc42 may regulate mitotic morphology and entosis, with RhoA emerging as a compelling candidate player. RhoA, another of the major small GTPases, has been implicated in mitosis (Chircop, 2014), mitotic rounding (Maddox and Burridge, 2003; Matthews et al., 2012) and cell-in-cell formation (Overholtzer et al., 2007) through previous studies. To investigate a possible role here, the spatiotemporal activation of RhoA was assessed using a FRET-based biosensor, RhoA-FLARE (Sun et al., 2014b; Pertz et al., 2006). Control or Cdc42-depleted 16HBE cells expressing the RhoA biosensor were subjected to live confocal imaging for CFP (FRET donor) and YFP (FRET acceptor), as well as DNA (Hoechst) and DIC (Figure 4a); RhoA activation is proportional to the FRET/CFP emission ratio. While control 16HBE cells show a relatively low level of RhoA activity during metaphase, a clear enrichment of active RhoA is frequently observed at the metaphase cortex among Cdc42-depleted cells (37%; Figure 4b). Related to this, an increase in cortical actin can also be observed among Cdc42-depleted, metaphase cells (Figure 4c). Together, these data indicate that Cdc42 constrains mitotic RhoA activation in polarised epithelial cells, and accordingly, that loss of Cdc42 permits overactivation of cortical RhoA during metaphase.

RhoA activity is spatiotemporally regulated by Cdc42 and controls mitotic spreading.

(a) 16HBE cells expressing a RhoA FRET biosensor were treated with siControl or siCdc42. Three days later, cells were subjected to live confocal imaging for CFP (FRET donor), YFP (FRET acceptor), DNA and DIC. RhoA activity is represented by the FRET/CFP emission ratio. Scale bars = 10 μm. (b) RhoA activity was measured in >30 metaphase cells per condition, across four independent experiments, and cortical enrichment of active RhoA was scored. **p<0.003, t-test. (c) Control or Cdc42-depleted 16HBE cells were fixed and stained for actin (green) or DNA (blue), and metaphase cells were imaged by IF/confocal. Representative sections and z-stacks are shown. Scale bar = 10 μm. (d) 16HBE cells were treated with siControl or siCdc42 and incubated for 3 days. Cdc42-depleted cells were then incubated with C3 (Rho inhibitor; 1 μg/ml), Y-27632 (ROCK inhibitor; 10 μM) or Blebbistatin (myosin inhibitor; 100 μM) for a further 4 hr. Live cells were stained for plasma membrane (white) and DNA (blue) and imaged by IF/confocal to assess metaphase morphology; scale bar = 15 μm. Representative z-stacks and basal sections are shown. (e) The spread basal area of each metaphase cell was measured. >15 cells were scored/condition, across three independent experiments. ****p<0.0001.

https://doi.org/10.7554/eLife.27134.015

RhoA activity controls mitotic morphology

To test whether deregulated RhoA activation influences mitotic morphology, live Cdc42-depleted cells were treated with a cell permeable form of C3 Transferase, a toxin that selectively ribosylates and inactivates RhoA/B/C (Barbieri et al., 2002), to block downstream signalling (Figure 4d). Although mitotic cells do remain somewhat rounded in the presence of this toxin, inhibition of the Rho proteins has a clear impact on mitotic spreading, yielding a significant increase in basal area, and thus partially reversing the effect of Cdc42-depletion (Figure 4e). These data are consistent with previous studies that have implicated RhoA activity in mitotic cell retraction, rigidity and rounding (Maddox and Burridge, 2003; Matthews et al., 2012), along with its targets ROCK (Maddox and Burridge, 2003; Meyer et al., 2011) and myosin (Matthews et al., 2012). To explore this observation further, live Cdc42-depleted cells were treated with additional pathway inhibitors, and suppression of ROCK (Y-27632) or myosin (blebbistatin) activity similarly rescued mitotic cell spreading in Cdc42-depleted cells (Figure 4d–e). Together, these data indicate that aberrant activation of a Rho/ROCK/myosin cascade during mitosis can drive enhanced retraction and rounding. Based on these findings, we would predict that RhoA inhibition may also suppress mitotic entosis upon Cdc42-depletion, by reverting these induced changes in mitotic morphology. Unfortunately, it is not possible to demonstrate this link unambiguously, because RhoA inhibition will block entotic cell-in-cell formation regardless of its trigger, due to downstream effects on myosin contractility (Overholtzer et al., 2007) and actin dynamics (Purvanov et al., 2014). As such, while we can clearly implicate RhoA in both mitotic rounding and cell-in-cell formation, we cannot definitively dissect the process of mitotic entosis further by targeting RhoA alone.

Enhanced mitotic deadhesion and rounding can induce entosis: Rap1

As an alternative approach to determine whether mitotic deadhesion and rounding is sufficient to drive entosis, mitotic morphology was manipulated through other means. Rap1 is yet another small GTPase, which, importantly here, is known to control post-mitotic spreading (Dao et al., 2009; Lancaster et al., 2013). Consistent with this, we confirm that expression of DN-Rap1 reduces spreading and increases rounding during 16HBE division (Figure 5a–d). Strikingly, inhibition of Rap1, like Cdc42, also induces adherent entosis, albeit at a lower level. Cell-in-cell formation among Rap1-inhibited cells occurs during or shortly after mitosis (Figure 5e–g, Video 6) and is inhibited by G2 arrest (Cdk1i). These data are consistent with a model in which enhanced mitotic deadhesion and rounding drive subsequent cell-in-cell formation. In light of these data, we next asked whether mitosis might promote entosis by simply providing an alternative route to matrix deadhesion in one cell of the pair (the dividing, internalised cell). To address this, we tested whether detached, interphase cells can similarly penetrate matrix-attached hosts. WT-16HBE cells were labelled green, detached and then either overlaid onto wild-type monolayers (adherent hosts) or maintained in suspension for 8 hr; the resulting cell-in-cell structures were scored (Figure 5h–i). Strikingly, while detached interphase cells undergo efficient entosis in suspension (~8%), penetration of adherent hosts is barely detectable. These data indicate that simple loss of matrix-attachment is insufficient to drive penetration of an adherent host. Consistent with this, entosis has not been observed among 16HBE-monolayers upon depletion of matrix-adhesion proteins (e.g. β1-integrin; Figure 5—figure supplement 1). Together, these data indicate that mitotic deadhesion and rounding, which can be augmented by inhibition of Cdc42 or Rap1, can drive the entotic penetration of an adherent host cell, while matrix-detachment during interphase cannot. These findings infer important mechanistic differences between cell cannibalism under detached and adherent conditions. We conclude that the distinctive biophysical changes associated with mitosis are an essential requirement when entosis occurs in an adherent host.

Figure 5 with 1 supplement see all
Enhanced mitotic deadhesion and rounding can drive entosis.

(a) Control (pQC) and DN-Rap1-HA expressing 16HBE cells were probed for HA, Rap1 and tubulin by western blot. (b) Control and DN-Rap1 expressing 16HBE cells were stained for cell body (green) and DNA (blue) and analysed by live confocal microscopy. Representative midplane x/y, and z sections through the dashed line, are presented. Arrowheads indicate metaphase cells, as identified by nuclear morphology. Quantification of (c) mitotic spreading (cell height/length) and (d) mitotic rounding (where 1 = a perfect circle) in control and DN-Rap1 16HBE cells. >10 metaphase cells were imaged per sample/experiment, across three independent experiments. Error bars denote mean±SD. ****p<0.0001, Mann-Whitney U test. (e) DN-Rap1 expressing 16HBE cells were analysed by timelapse microscopy. A mitotic cell (Cell 1) is outlined in white, the adherent entotic host (Cell 2) in yellow. Timestamps are indicated (hr:min) and scale bar = 10 μm. (f) Representative confocal image of an adherent cell-in-cell structure in DN-Rap1 expressing 16HBE cells, fixed and stained for the cell body (green) and DNA (blue). Scale bar = 10 μm. (g) Quantification of cell-in-cell formation in adherent control and DN-Rap1 cells, treated −/+ a Cdk1 inhibitor that induces G2/M arrest (5 μM RO-3306; Cdk1i). >250 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. *p<0.03, t-test. (h) Representative images from a co-culture of suspension wild type 16HBE cells, labelled with CellTracker (green), overlaid on an existing monolayer of wild type 16HBE cells stained for DNA (blue). Co-cultures were monitored for 8 hr by timelapse microscopy. DIC/IF images are shown at time 0 and 8 hr; the detached population (green) are highlighted with red arrows; these cells can persist throughout the timecourse and very rarely penetrate adherent hosts. (i) Quantification of cell-in-cell formation under adherent conditions as described in (h), and under suspension conditions. >300 cells were counted per sample/experiment, across three independent experiments. Error bars denote mean±SEM.

https://doi.org/10.7554/eLife.27134.017
Video 6
Mitosis-driven entosis in adherent 16HBE cells expressing DN-Rap1.

DIC images from Widefield timelapse. A daughter of cell 1 is engulfed by cell 2.

https://doi.org/10.7554/eLife.27134.020

Mitosis-induced entosis occurs constitutively in adherent cancer cell lines and human tumours with pleiotropic effects

Given that tumour cells are prone to undergo deregulated division and that mitotic rounding is proposed to be of relevance in cancer (Cadart et al., 2014), we hypothesised that transformed cells may undergo mitotic entosis constitutively. To test this, adherent cancer cell lines were examined by fixed and live microscopy. Interestingly, MCF7 (breast) and HCT116 (colorectal) cells were found to undergo adherent entosis under basal conditions. Importantly, cell-in-cell formation is coincident with cell division, as shown by timelapse microscopy (Figure 6a–b, Videos 78), and is largely dependent on progression through mitosis, in both 2D and 3D culture (Figure 6c–d). These data indicate that mitosis drives constitutive adherent entosis in certain transformed tumour cell lines and raise the interesting possibility that cell division may promote cell cannibalism in the proliferative environment of a tumour. To investigate this more directly, a tissue microarray of 75 human breast invasive ductal carcinomas was analysed (Figure 6e–g, Supplementary file 1). Each tumour core was stained for DNA, β-catenin and p-Histone-H3 (pS10; a mitotic marker), and then imaged in full and scored for mitotic activity (mitotic cells/core) and entosis (cell-in-cell structures/core). 31/75 ductal carcinomas were positive for entosis, and among these, mitotic activity positively correlates with cell-in-cell formation, with statistical significance (Figure 6g). These data are consistent with the notion that mitosis may drive entotic cell-in-cell formation in vivo. During conventional entosis, the inner cell is typically killed (Overholtzer et al., 2007; Florey et al., 2011; Wan et al., 2012), while the outer cell is rendered prone to division failure (Krajcovic et al., 2011; Wan et al., 2012). To determine whether similar anti- and pro-tumorigenic consequences accompany mitotic entosis among adherent cancer cells, the outcomes were followed by timelapse and IF/confocal microscopy. Similar to suspension conditions, cell death is the predominant fate for internalised cells following mitotic entosis, which can occur by either non-apoptotic and apoptotic means (Figure 6h–i). Host cell division failure was also analysed by scoring for multinucleation. Again, similar to suspension entosis, host cells are more frequently multi-nucleated than surrounding single cells, suggesting that abscission can be disrupted by entosis in adherent, as well as matrix-detached, conditions (Figure 6j–k). Together, these data establish that mitosis-induced entosis occurs basally in adherent cancer cell lines and human breast carcinomas. Mitosis-induced entosis can drive inner cell killing, a potentially tumour suppressive effect, but also promotes host cell multi-nucleation, a route to tumour-promoting genomic instability. These findings uncover an intriguing relationship between cell division and cannibalism, of potential functional significance during tumour development and evolution.

Mitosis-induced entosis occurs in cancer cell lines and human tumours, with pleiotropic effects.

(a–b) Adherent cancer cell lines MCF7 (breast) and HCT116 (colorectal) were analysed by timelapse microscopy; representative cell-in-cell formation events are shown. In each case, a mitotic cell (Cell 1, outlined in white) is internalised by an adherent neighbour (Cell 2, outlined in yellow). Timestamps are shown (hr:min) and scale bar = 20 μm. (c) Quantification of cell-in-cell formation in adherent MCF7 cells cultured in 2D or 3D, treated +/− a Cdk1 inhibitor that induces G2/M arrest (5 μM RO-3306; Cdk1i). >300 cells for 2D and >50 cells for 3D were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. **p<0.002; *p<0.02, t-test. (d) MCF7 cells seeded in 3D matrigel were treated −/+5 μM RO-3306 overnight, then fixed and stained for β-catenin (green) and DNA (blue). Two to four cell cysts were imaged to assess mitotic status and cell-in-cell formation. Representative sections are shown; scale bar = 10 μm. (e) Human breast invasive ductal carcinoma. A tumour microarray was stained for β-catenin (green), pS10-Histone H3 (red, mitotic marker) and DNA (blue) and imaged in full by DIC and IF/confocal. A tiled confocal image is presented for one core. Scale bar = 200 μm. (f) Entosis in a human invasive breast ductal carcinoma. A representative cell-in-cell structure is shown by DIC and IF/confocal; notably the inner cell is mitotic as judged by pHH3. Scale bar = 10 μm. (g) Quantification of mitotic index and cell-in-cell formation among human breast invasive ductal carcinomas. The median number of mitotic cells/core is 24. *p<0.05, Mann-Whitney test. (h) Representative timelapse series showing inner cell death in an MCF7 cell-in-cell structure, stained for DNA (blue). The internalised cell is outlined in yellow; its corpse shrinks over time. Timestamps are indicated (hr:min) and scale bar = 10 μm. (i) Quantification of inner cell fate in MCF7 entotic structures over 20 hr. Fifty-four cell-in-cell structures were analysed over three independent experiments. (j) Representative image of a multinucleated, entotic host cell in adherent MCF7 stained for cell body (green) and DNA (blue). Scale bar = 10 μm. (k) Quantification of MCF7 multinucleation in single cells versus entotic hosts cells. Error bars denote mean±SEM across three independent experiments. **p<0.008, t-test.

https://doi.org/10.7554/eLife.27134.021
Video 7
Mitosis-driven entosis in adherent MCF7 cells.

DIC and DNA(Hoechst) images from Widefield timelapse. A daughter of cell 1 is engulfed by cell 2.

https://doi.org/10.7554/eLife.27134.023
Video 8
Mitosis-driven entosis in adherent HCT116 cells.

DIC images from Widefield timelapse. Cell 1 is engulfed by cell 2 during mitosis.

https://doi.org/10.7554/eLife.27134.024

Taxane treatment promotes mitosis-induced entosis

Many cancers are treated chemotherapeutically with taxanes (e.g. Paclitaxel), which can induce prometaphase arrest, multipolar division and cell death (Zasadil et al., 2014). As such, we hypothesised that taxane treatment might influence cell cannibalism by modulating mitotic entosis. To test this, 16HBE cells were incubated in the presence or absence of taxol, then imaged by timelapse or IF/confocal microscopy (Figure 7a–c, Video 9). As expected, taxol treatment increases mitotic index under these conditions, arresting the cells in prometaphase (in contrast to Cdk1i which arrests at G2/M, inhibiting entry into mitosis). Importantly, taxol treatment also consistently increases cell-in-cell formation under these conditions, in line with an induction of mitotic entosis. This effect can be phenocopied with additional drugs that inhibit mitotic progression through different mechanisms, including nocodazole (microtubule assembly inhibitor) and STLC (mitotic kinesin inhibitor), suggesting that entosis occurs as a consequence of prometaphase arrest rather than microtubule stabilisation. Strikingly, we also find that taxol, nocodazole and STLC significantly enhance mitotic deadhesion and rounding (Figure 7d–f), thus independently supporting the model that changes in mitotic morphology are closely associated with adherent cell-in-cell formation. To investigate whether taxane-induced cell cannibalism may be of chemotherapeutic significance, MCF7 breast cancer cells were examined. In both cultured cells (Figure 7g–h) and mouse xenograft models (Figure 7i–l), 24 hr taxol treatment promotes a significant increase in mitotic index, and a corresponding induction of cell-in-cell formation, consistent with mitosis-induced entosis. Notably, as taxol is reported to inhibit MCF7 entosis in suspension (Xia et al., 2014), these data further suggest that the mechanisms of detached versus adherent cell-in-cell formation are quite distinct. Together, our findings establish that taxane treatment enhances mitotic deadhesion and rounding and promotes cell cannibalism through entosis, and reinforce the conclusion that changes in mitotic morphology can drive adherent entosis. Moreover, these findings uncover some intriguing and unconventional new effects of taxane treatment, of potential chemotherapeutic interest.

Paclitaxel/taxol treatment promotes mitotic deadhesion, rounding and entosis.

(a) Representative timelapse images of adherent 16HBE cells treated with 1 μM taxol. Cell 1 (outlined white) rounds up in prometaphase and subsequently penetrates an adherent interphase neighbour (Cell 2, outlined yellow). Timestamps are shown (hr:min) and scale bar = 10 μm. (b) Representative confocal/DIC images of adherent cell-in-cell structures in 16HBE treated with taxol (1 μM), nocodazole (100 ng/ml) or STLC (20 μM) for 24 hr. Cells were stained for DNA (blue), scale bar = 10 μm. (c) Quantification of drug-induced cell-in-cell formation. >150 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. **p<0.002; *p<0.02, t-test. (d) Mitotic morphology of 16HBE cells treated with taxol (1 μM), nocodazole (100 ng/ml) or STLC (20 μM) for 24 hr. Live cells were stained for cell body (green) and DNA (blue). Midplane x/y, and z sections through the dashed line, are presented. Scale bar = 10 μm. Quantification of (e) mitotic spreading (cell height/length) and (f) mitotic rounding (where 1 = a perfect circle) in control and drug-treated cells. >15 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SD. ****p<0.0001, Mann-Whitney U test. (g) Representative confocal images of partially and completely formed cell-in-cell structures in MCF7 cells treated with taxol (1 μM), and stained for β-catenin (green) and DNA (blue). The arrowheads point to prometaphase arrested cells internalised by adherent, interphase neighbours. Scale bar = 10 μm. (h) Quantification of taxol-induced entosis in MCF7. >150 cells were counted per sample/experiment, across three separate experiments. Error bars denote mean±SEM. *p<0.04, t- test. (i) Confocal images of MCF7 xenografts treated −/+ taxol for 24 hr and stained for phospho-Histone H3 (pHH3, red) and DNA (blue). Scale bar = 50 μm. (j) Quantification of pHH3-positive, mitotic cells in MCF7 mouse xenografts treated −/+ taxol for 24 hr. ****p<0.0001, t-test. (k) Representative confocal and DIC images of an entotic cell-in-cell structure in a taxol-treated MCF7 xenograft, stained for β-catenin (green) and DNA (blue). Scale bar = 10 μm. (l) Quantification of cell-in-cell formation in MCF7 mouse xenografts treated −/+ taxol for 24 hr. *p<0.01, t-test.

https://doi.org/10.7554/eLife.27134.025
Video 9
Mitosis-driven entosis in adherent 16HBE cells treated with taxol (1 μM).

DIC images from Widefield timelapse. Cell 2 enters mitosis and is engulfed by cell 1.

https://doi.org/10.7554/eLife.27134.027

Discussion

Cell cannibalism has been observed within tumours for over a century (Overholtzer and Brugge, 2008; He et al., 2013; Lozupone and Fais, 2015), but its underlying mechanisms and functional consequences remain to be fully understood. Entosis is a form of homotypic epithelial cell cannibalism that is typically triggered by matrix-deadhesion, and which proceeds through junction formation and the generation of actomyosin contractility, culminating in cell engulfment and killing (Overholtzer et al., 2007). This process is regulated at various stages by Rho-family small GTPases, which govern the cytoskeletal and junctional components upon which entosis depends (Overholtzer et al., 2007; Sun et al., 2014a; Purvanov et al., 2014).

This study set out to address whether Cdc42, a master regulator of epithelial biology (Jaffe and Hall, 2005; Heasman and Ridley, 2008; Joberty et al., 2000; Martin-Belmonte et al., 2007; Jaffe et al., 2008; Wallace et al., 2010; Roignot et al., 2013), controls entosis. Surprisingly, despite its well-documented control of the cytoskeleton, polarity and epithelial junctions (Etienne-Manneville, 2004), Cdc42 has little effect on entosis among cells cultured in suspension. Unexpectedly, however, we found that loss of Cdc42 can in fact promote robust cell-in-cell formation among adherent cells. This result was very surprising, because entosis is not expected to occur under these conditions (Overholtzer et al., 2007), but, this process otherwise bears its hallmarks, involving cell-cell contacts (Sun et al., 2014b; Wang et al., 2015), polarised actomyosin (Sun et al., 2014a), autophagy proteins (Florey et al., 2011) and lysosomes (Krajcovic et al., 2013). Notably, some similar, adherent engulfment events have been noted previously (Lai et al., 2010; Abreu and Sealy, 2012), and in the present study, we clarify that entosis can indeed occur among matrix-attached cells, and define the associated mechanism.

Cdc42 is known to regulate cell-matrix contacts through β1-integrin in certain cancer cells (Reymond et al., 2012), so it is plausible to hypothesise that its depletion may weaken focal adhesions, or impair integrin signalling, to mimic detachment and so induce entosis. However, our data are not consistent with this model. Firstly, control monolayers can efficiently internalise Cdc42-depleted neighbours, demonstrating that entotic hosts can be wild-type and therefore fully adherent. Secondly, neither enzymatic deadhesion, nor depletion of β1-integrin, is sufficient to drive one population of cells to penetrate surrounding adherent neighbours. Together, these data indicate that general changes in matrix-binding are unlikely to fully account for adherent entosis.

In this study, we identify mitosis as a novel trigger for entosis. We show that mitosis is indispensable for adherent cell-in-cell formation, with entosis occurring during, or shortly after, cell division, and requiring transit through G2/M. In contrast, mitosis is not necessary for entosis in suspension, indicating that quite distinct mechanisms operate under different growth conditions. Our findings identify an important new route to entosis and uncover an intriguing relationship between epithelial cell division and cannibalism, of particular interest in the context of a proliferative and nutrient-deprived tumour.

Cdc42 activity is known to be cell-cycle regulated (Yoshizaki et al., 2003) and to control certain mitotic processes, including kinetochore attachment and chromosome segregation (Chircop, 2014; Yasuda et al., 2004); however, these roles appear unrelated to cell cannibalism. We have also found little evidence to support a role for aPKC as a Cdc42 effector during adherent entosis, likely excluding mechanisms involving the polarity complex (Joberty et al., 2000), such as junctional remodelling (Wallace et al., 2010), spindle orientation (Durgan et al., 2011), or control of the metaphase cortex (Rosa et al., 2015). Instead, we have discovered an additional role for Cdc42 in regulating mitotic morphology, consistent with previous observations in NRK (Zhu et al., 2011) and HeLa (Mitsushima et al., 2009) cells. Upon Cdc42 depletion, mitotic deadhesion and rounding are significantly enhanced. These phenotypes are associated with a prominent increase in cortical RhoA activity, and can be reverted by inhibition of RhoA, or its downstream effectors ROCK and myosin, consistent with previous work (Maddox and Burridge, 2003; Matthews et al., 2012). We conclude that Cdc42 plays a novel role in the regulation of mitotic morphology in polarised epithelial cells, in a RhoA/ROCK/myosin-dependent manner. It is interesting to note that this Rho-dependent signalling axis is also required for entosis among suspension cells (Overholtzer et al., 2007; Sun et al., 2014a; Wan et al., 2012; Li et al., 2015), suggesting that some interesting mechanistic parallels exist between these alternative routes to cell cannibalism.

The augmentation of mitotic deadhesion and rounding induced by Cdc42 suppression can be phenocopied by inhibition of Rap1, or through drug-induced prometaphase arrest, and, importantly, in each case is followed by subsequent cell-in-cell formation (Figure 8). Putting together the data from these diverse conditions, we conclude that the distinctive biophysical changes associated with mitotic deadhesion and rounding may uniquely enable a dividing cell to penetrate an adherent epithelium, by which it is ultimately cannibalised. These findings add to the emerging concept that mitotic shape changes bear important functional consequences (Lancaster et al., 2013; Cadart et al., 2014; Théry and Bornens, 2006; Gibson et al., 2011; Luxenburg et al., 2011; Kondo and Hayashi, 2013; Sorce et al., 2015), of particular significance within tumours (Sorce et al., 2015).

The triggers and consequences of entosis in cancer.

Entosis can be triggered among epithelial cells through either matrix deadhesion or aberrant mitosis. Mitotic entosis is associated with enhanced deadhesion and rounding during cell division, which can be induced by inhibition of Cdc42 or Rap1, or through prometaphase arrest. RhoA activity is important in both suspension and mitosis-induced entosis, driving ROCK-dependent myosin activation. Regardless of the triggering mechanism, entosis promotes both inner cell death and outer cell nutrient gain and multi-nucleation, with the potential to confer both anti- and pro-tumorigenic effects.

https://doi.org/10.7554/eLife.27134.028

We report that the process of mitosis-induced entosis is observed basally among certain cancer cell lines, establishing a broader biological incidence of this process. Moreover, we find that mitotic index positively and significantly correlates with cell-in-cell formation in human breast invasive ductal carcinomas, consistent with a pathophysiological occurrence in vivo. Importantly, as mitotic index is one of the key criteria used to stage breast cancers, our findings can in part explain the increased frequency of cell-in-cell structures among higher grade, more proliferative tumours (Krajcovic et al., 2011; Gupta and Dey, 2003; Abodief et al., 2006). Our study thus contributes new insights into the field of cell cannibalism in cancer, building on the emerging notion that cell-in-cell formation correlates with more aggressive disease (Krajcovic et al., 2011) and may provide prognostic indications (Schwegler et al., 2015; Schenker et al., 2017).

In relation to cancer, we also report the chemotherapeutic induction of mitotic entosis as a novel and unanticipated effect of Paclitaxel/taxol treatment. Interestingly, we find that Paclitaxel enhances mitotic deadhesion and rounding, thereby driving subsequent cell-in-cell formation through entosis. There is a significant debate regarding the mechanism of action of taxane-family drugs (Weaver, 2014), which can cause prometaphase arrest, multipolar divisions and cell death (Zasadil et al., 2014). As such, these additional and unconventional activities in modifying mitotic morphology and driving cell cannibalism through entosis may be of potential clinical interest.

Finally, we show that the outcome of entosis is broadly conserved, whether it is triggered by deadhesion or mitosis, within an adherent or detached host cell (Figure 8). On one hand, entosis drives internalised cell killing, a potential means of limiting growth (Florey et al., 2011). We find here that the host cell can be wild-type and fully adherent, developing an intriguing model in which aberrantly dividing cells may penetrate, and be eliminated by, the surrounding normal epithelium, in a tumour-suppressive act of ‘assisted suicide’. On the other hand, we also show that mitosis-induced entosis can disrupt host cell division, with the potential to drive genomic instability (Krajcovic et al., 2011). In this case, an alternative model emerges in which one aberrant division promotes more, thereby contributing to tumour progression. These models are not mutually exclusive and the overall impact of entosis on tumour biology remains the focus of ongoing work (Durgan and Florey, 2015).

In conclusion, we propose that there are at least two mechanistic routes to entosis: loss of matrix-attachment and cell division. It is striking that anchorage independence and unrestrained proliferation, two classic hallmarks of cancer (Freedman and Shin, 1974; Hanahan and Weinberg, 2011), can both drive this form of cell cannibalism, so commonly observed in tumours. It will be worthwhile through future work to assess whether additional features of cancer cells (e.g. stemness), or their environments (e.g. hypoxia, nutrient deprivation), may similarly trigger entosis, and to more comprehensively investigate the effects of cell cannibalism on tumour development, progression and evolution.

Material and methods

Cell culture and treatments

Cells were obtained from the following sources: 16HBE (Durgan et al., 2015) (from lab of Dieter Gruenert, UCSF), MCF7 (Sun et al., 2014a) (Lombardi Cancer Center, Georgetown University), HCT116 (Sun et al., 2014a) (from lab of David Boone, University of Notre Dame), 293FT (Durgan et al., 2011) (Invitrogen); all tested negative for mycoplasma (MSKCC core facility) and were cultured as described previously. The following inhibitors were used: Blebbistatin (100 μM; Sigma, UK), C3 Transferase (1 μg/ml; CT04 Cytoskeleton, Denver, CO), Nocodazole (100 ng/ml; Sigma), RO-3306 (5 μM; Sigma), STLC (20 μM, Santa Cruz, Dalla, TX), Taxol (1 μM; EMD), Y-27632 (10 μM; R&D, Minneapolis, MN); high-grade DMSO was used as a carrier control (1:1000; Sigma).

Retrovirus production and infection

For stable expression of shRNA (pSUPER, shCdc42.1 and 2, pSiren, shITGB1.1, shITGB1.2) or protein (GFP, RFP-zyxin, HA-DN-Rap1, RhoA biosensor), cells lines were generated by retroviral infection and selection as described previously (Durgan et al., 2011). Briefly, cells were seeded at 105 cells/6-well, infected by centrifugation and stable cells were selected with Puromycin (1.5 μg/ml for 16HBE, 2.5 μg/ml for MCF7) for 2–5 days. Short-term stable pools of cells were prepared for each experiment to avoid clonal effects.

shRNA

shRNA Cdc42 depletions were performed using hairpins cloned into pSUPER Puro vector: shCdc42.1 (cctgatatcctacacaacaaa), shCdc42.2 (cagatgtatttctagtctgtt). β1 integrin (ITGB1) depletions were performed using hairpins cloned into pSiren Puro vector: shITGB1.1 (gccttgcattactgctgat), shITGB1.2 (gccttgcattactgctgatat). Stable pools were seeded at 2.5 × 104 cells/24-well and incubated for 3 days before analysis. siRNA depletions were performed using the following duplexes (Dharmacon, Lafayette, CO): siControl (siLamin A/C; D-001620–02), siCdc42.1 (gauuacgaccgcugaguua), siCdc42.2 (cggaauauguaccgacugu), siα-catenin SMARTpool (M-010505-01-0005). 16HBE cells were transfected using Lipofectamine LTX as described previously (Durgan et al., 2015). Briefly, cells were seeded at 2.5 × 104 cells/24-well and transfected with 1.25 μl Lipofectamine LTX + 1.25 μl 20 μM siRNA (or 10 μM + 10 μM for co-depletions) in antibiotic-free media, overnight. Media was changed the following day, with or without inhibitors (see figure legends), and cells incubated for at least 3 days to optimise knockdown levels.

Western blotting

Western blotting was performed as described previously (Durgan et al., 2008). The following antibodies were used in this study: α-catenin (Sigma C2081; RRID:AB_476830; 1:1000; blocked with 5% milk), Cdc42 (BD 610929; RRID:AB_398244; 1:250), GAPDH (Santa Cruz 25778; RRID:AB_10167668; 1:2000), HA (Covance MMS-101R; RRID:AB_291262; 1:2000; blocked with 5% milk), ITGB1 (cytoSM158, kindly provided by Dr Filippo Giancotti; 1:2500 blocked with 5% milk), Rap1 (Millipore 07–916; RRID:AB_2177126; 1:1000; blocked with 5% milk), α-tubulin (Serotec MCA77S; 1:2000; blocked with 5% milk). Representative images of blots are shown.

FACS

2 × 105 shControl or shCdc42-16HBE cells were seeded on 60 mm dishes and incubated for 2 days. These cycling populations were fixed with EtOH and stained with propidium iodide as described previously (Durgan et al., 2011). DNA content was analysed using a FACSCaliber to capture 10,000–30,000 events/sample. Analysis was performed using FlowJo software.

Immunofluorescence

Unless otherwise indicated, immunofluorescence (IF) was performed as described previously (Durgan et al., 2015). Briefly, cells were fixed using 3.7% formaldehyde in PBS (10 min, RT), permeablised in 0.5% triton (5 min, RT) and then incubated with primary antibody in PBS (4C, overnight): β-catenin (BD 610153; RRID:AB_397554; 1:100), p-MLC2 (Cell Signalling 3671L; RRID:AB_330249; 1:100), LC3 (Cell Signalling 4108; RRID:AB_2137703; 1:100), LAMP1 (BD 555798; 1:100), p-Histone H3 (Millipore 06–570; RRID:AB_310177; 1:100), ZO-1 (Invitrogen 61–7300; RRID:AB_2533938; 1:100). Cells were washed in PBS and incubated with Alexa Fluor 488/568 goat anti-mouse/rabbit (H+L) secondary (1:500) and Hoechst 3342 (1μg/ml) for 45 min at RT; where indicated, HCS CellMASK Deep Red (Thermofisher, H32721) or Alexa Fluor 488-phalloidin (Cell Signalling, 8878S) were included, to stain the cell body or actin respectively, according to the manufacturers’ guidelines. Cells were washed with PBS, then water, and mounted using Prolong Gold Antifade Mountant (Thermofisher). Image acquisition was performed with a Confocal Zeiss LSM 780 microscope (Carl Zeiss Ltd) equipped with a 40X oil immersion 1.4 NA objective, using Zen software (Carl Zeiss Ltd).

Live imaging

Cells were seeded on glass-bottomed dishes (Mattek, Ashland, MA) and incubated/treated as shown in figure legends. Where indicated, cells were stained with CellTracker Green CMFDA, CellTracker Red CMTPX or CellMASK deep red plasma membrane stain (Invitrogen, C10046) for 30 min, as recommended by the manufacturer (Thermofisher) and with Hoechst 33342 (1 μg/ml, Sigma), then washed and returned to normal growth media for imaging. All live microscopy were performed in an incubation chamber at 37°C, with 5% CO2; for overnight imaging, media was overlaid with mineral oil to prevent evaporation. For widefield timelapse microscopy, fluorescent and DIC images were acquired every 8 min using a Flash 4.0 v2 sCMOS camera (Hamamatsu, Japan), coupled to a Nikon Ti-E inverted microscope, using a 20 × 0.45 NA objective. Image acquisition and analysis was performed with Elements software (Nikon, Japan). For live confocal imaging, the same microscope, camera and software were used as described in the section above.

FRET analysis of RhoA biosensor

For emission ratio imaging, 16HBE cells stably expressing the RhoA-FLARE biosensor (a gift from Dr Klaus Hahn, Addgene #12602) were seeded on 35 mm glass bottom dishes (Mattek) and treated with siRNA as indicated. Hoechst 33342 was added prior to image acquisition. FRET images were acquired with a Zeiss 780 confocal system equipped with a 40 × 1.4 NA objective lens. 458 nm excitation light was used to excite the donor (CFP), with donor emission collected, 464–490 nm, and acceptor (YFP) emission collected, 535–588 nm. Images were typically taken with a pixel size of 80 nm, a pixel dwell time of 0.97 ms and the pinhole set to 2 Airy units. Images were processed using ImageJ. Briefly, all images were background subtracted and the FRET image was used to make a binary mask and selection region. The FRET image was then divided by the CFP image yielding a ratio image reflecting RhoA activity. A linear pseudocolour lookup table was applied. Only cells that had a high enough signal-to-noise ratio in both the CFP and FRET signals were used.

3D-CLEM

Cdc42-depleted cells were cultured on 35 mm gridded glass-bottomed dishes (MatTek). Cells were stained using CellTracker Green, CellMASK Plasma Membrane dye and Hoechst, then analysed by live confocal microscopy. A mitotic cell-in-cell formation event was identified, imaged and its position recorded. The cells were quickly fixed, processed, imaged and analysed by correlative serial block face scanning electron microscopy as described previously (Russell et al., 2017).

Cell-in-cell formation assays: suspension culture

Cells were trypsinised on day 3 post-seeding or transfection, resuspended in growth media, −/+ inhibitors, and seeded at 105 cells/six-well on ultra-low adhesion dishes (Costar) for 8 hr. Following suspension culture, 5 × 104 cells were transferred to a glass slide by cytospin at 300 rpm for 3 min, fixed in 10% TCA and analysed by IF/confocal.

Cell-in-cell formation assays: adherent culture

Cells were seeded on glass coverslips or glass-bottomed dishes, treated −/+ siRNA as indicated, and incubated for 3 days. To analyse the effects of taxol, nocodazole and STLC, the drugs were added to WT cells for a further 24 hr. To analyse the effect of Cdk1 inhibition, a Y-27632 wash-out experiment was performed. Following siRNA transfection (16HBE) or seeding (16HBE-DN-Rap1, MCF7), media was replaced with 10 μM Y-27632, to inhibit entosis. This treatment allowed a monolayer to form in the absence of cell-in-cell formation, thereby yielding a clean background. 3 days later, Y-27632 was washed out, to permit entosis, and replaced with either control media or 5 μM RO-3306 (a Cdk1 inhibitor). Cells were fixed and analysed 24 hr later.

Inner/outer cell identity assays

105 WT or GFP-expressing 16HBE cells were seeded per six-well and transfected with siControl or siCdc42.2, respectively. WT cells were treated with Cell Tracker Red for 30 min, and then both cell lines were trypsinised, mixed in equal proportion, then reseeded at 105 cells/well on 35 mm glass bottomed dishes to yield mixed monolayers. 2 days later, the resulting entotic structures were analysed by live IF/confocal microscopy (d3 post-siRNA). The colours could be reversed with no change in experimental outcome (ie. siControl/GFP cells, siCdc42/WT-red cells).

Mitotic morphology assays

105 16HBE cells were seeded/35 mm glass-bottomed dish and transfected with siCdc42. Three days post-transfection, the cells were stained with CellTracker Green and Hoechst for 30 min, then placed in fresh media for imaging. Metaphase cells were imaged by live DIC and confocal microscopy, with full z-stacks acquired. Images were analysed using ImageJ software. To measure mitotic cell spreading, cell length was measured in a basal x/y section, cell height in the z, and height/length ratio was plotted. For mitotic rounding, cell shape was analysed in the midplane x/y section of each metaphase cell, scoring for roundness (where 1 = a perfect circle).

Mitotic spreading assays

105 16HBE cells were seeded/35 mm glass-bottomed dish and transfected with siControl or siCdc42. On day 3 post-transfection, Cdc42-depleted cells were stained with Hoechst and treated with C3 (1 μg/ml), Y-27632 (10 μM) or Blebbistatin (100 μM) for a further 4 hr. 10 min prior to imaging, each dish of cells was treated with CellMASK deep red plasma membrane stain (Invitrogen, C10046), and cells subjected to live IF/confocal imaging. Metaphase cells were identified by DNA morphology and the basal section imaged. Basal spread area was measured using ImageJ.

3D culture

MCF7 cells were seeded in 3D matrigel using established protocols (Durgan et al., 2011), and incubated to form early stage cysts (2–4 cells) in which matrix contacts are retained, to minimise the induction of detachment-induced entosis. Briefly, four-well, glass-bottomed chamber slides (Lab-Tek II; 155382) were coated with a thin layer of 80% Matrigel Growth Factor Reduced Membrane Matrix (Corning; 356230)/20% Rat Collagen I (Cultrex; 3440-100-01), then overlaid with 5 × 104 cells in 2% Matrigel/media; 10 μM Y-27632 was included to suppress basal detachment-induced entosis during seeding. Cells were incubated for 24 hr to initiate cyst formation, Y-27632 was then washed out and replaced with fresh media −/+ RO-3306 (5 μM), to allow cell-in-cell formation to proceed in 3D, in the presence or absence of mitosis. Twenty-four hour later, cysts were formalin fixed, stained for actin (488-phalloidin) and DNA (Hoechst) and imaged by confocal microscopy.

Tissue microarray (TMA)

A human breast cancer microarray was obtained from US Biomax (BR1505b), bearing 75 cases of invasive ductal carcinoma (see Supplementary Figure 2). Each case was represented by duplicate formalin-fixed, paraffin-embedded cores, each with a diameter of 1 mm and a thickness of 5 μm. The array was baked at 55°C for 30 min, deparaffinised in xylene (2 × 10 min washes, RT) and rehydrated through sequential washes (2 × 100% EtOH, 1 × 70% EtOH, 1 × 30% EtOH, 3x H2O; 5 min each at RT). Antigens were retrieved by boiling in 1x citrate buffer (Vector Labs) for 20 min, then cooled back to RT. Blocking (45 min, RT) and antibody incubations were performed in TBS-T/5% BSA/0.1M Glycine; TBS-T was used for washes. Antibodies and mounting conditions are stated above (see IF), with primaries incubated 4°C/overnight, secondaries at RT/45 min and DAPI at RT/10 min. The array was stained for: (1) β-catenin, to visualise adherens junctions (where present), (2) p-Histone H3 (S10), a marker of mitosis, and (3) DAPI to visualise nuclear morphology. Each 1 mm core was imaged in whole by DIC and confocal microscopy, using a 40 × 1.4 NA objective and tiling a 6 × 6 grid. For each core, the number of p-Histone H3 (S10)-positive nuclei was counted as an indicator of mitotic activity, and the number of cell-in-cell structures scored as a measure of entosis.

Xenografts

Six- to 8-week-old female athymic mice were implanted with β−17 estradiol pellets 3 days before tumor implantation. 1 × 107 MCF7 cells were injected subcutaneously per tumour, in duplicate. When tumours reached a size of ~150 mm3, mice were treated with either vehicle, or 15 mg/kg taxol. Twenty-four hour post-treatment, tumours were excised, formalin-fixed and 20 micron sections were prepared (these relatively thick sections permit complete visualisation of whole engulfed cell-in-cell structures). Sections were processed and stained as described for the TMA, and analysed by DIC and IF/confocal (β-catenin, p-HH3/DNA). To account for tumour heterogeneity, five well-separated fields of view (x/y) were captured from each of three distinct sections per tumour (z; from the top, middle, bottom) using a 40 × 1.4 NA objective. The average number of pHH3-positive cells was scored per FOV, per section. The total number of cell-in-cell structures in each section was scored.

Statistics

Data were analysed by Mann-Whitney U test and Student t-test as indicated, using Prism 6 software.

Data availability

All relevant data are available from the authors.

References

  1. 1
  2. 2
  3. 3
  4. 4
    Serum-dependent "cannibalism" and autodestruction in cultures of human small cell carcinoma of the lung
    1. M Brouwer
    2. L de Ley
    3. CA Feltkamp
    4. J Elema
    5. AP Jongsma
    (1984)
    Cancer Research 44:2947–2951.
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
    A fascinating act of cellular cannibalism
    1. J Durgan
    2. O Florey
    (2015)
    Laboratory News. Accessed December 17, 2015.
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
    Progress of research in cell-in-cell phenomena
    1. YQ Yang
    2. JC Li
    (2012)
    The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 295:372–377.
    https://doi.org/10.1002/ar.21537
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71

Decision letter

  1. Alpha Yap
    Reviewing Editor; The University of Queensland, Australia

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

[Editors’ note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.]

Thank you for submitting your work entitled "Mitosis can drive cell cannibalism through entosis" for consideration by eLife. Your article has been favorably evaluated by Anna Akhmanova (Senior Editor) and three reviewers, one of whom, Α Yap, is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in eLife.

Let me summarize: we all consider the phenomenon that you report to be interesting and its phenomenology to be convincingly described. However, there are two broad areas where we feel that it is still lacking to be appropriate for eLife.

Firstly, we feel that more mechanistic insight is needed. Overall, we think that this is the key area where the manuscript needs to be advanced. You will see that the reviewers have suggested a range of areas that could be investigated, ranging from some measure of the biophysical changes in the to-be-entosed cells (as could be inferred from cell shape changes: Reviewers 1 and 3), to changes in the balance of GTPase signaling and adhesion. Of course, this is a wide range of suggestions, not all of which would need to be followed to reasonably strengthen the manuscript. We will leave it to your judgement to consider what is feasible from your perspective.

Secondly, the link to cancer could also be strengthened. On balance, we think that this is less important. Reviewer 2 has suggested a range of possibilities, some of which (such as the use of organoid or 3D cultures) would be exciting but beyond the reasonable scope of a revision. Here we ask you to focus on 2 discrete aspects: a) What might be the association with prognosis; and b) whether there is a link to a change in GTPase balance (over-activation of RhoA or downregulation of Cdc42).

Our policy is to not ask for extensive revisions that will take more than two months to complete. Therefore, whilst we do find this work interesting, we feel it will take considerably longer than two months to investigate the above points that would make your study a more substantial contribution. Hence, we are rejecting it for now but would be open to a revised manuscript if the mechanistic insights and links to cancer were explored. This paper would be treated as a new submission with no guarantees of acceptance, but we will endeavour to secure the same referees. Alternatively, you are of course also free to submit your work elsewhere if you would like to publish sooner rather than later.

Reviewer #1:

This manuscript explores the phenomenon of entosis, a still-enigmatic process whereby cells can be engulfed and ultimately killed, by neighbouring cells. To date, entosis has generally been observed when cells are grown in suspension. In contrast, Durgan et al. now document circumstances when substrate-adherent cells undergo entosis. They show that this is associated with mitosis, when either Cdc42 or Rap1 signaling are perturbed, maneuvers that promote deadhesion and cell rounding. Further, they show evidence that this process may occur in tumors, and can be promoted by chemotherapeutic agents that target microtubules or mitotic kinesins.

Overall, these are interesting observations, but – though thorough – the analysis remains somewhat phenomenological. My appreciation of the (patho)biologic and/or mechanistic significance of these findings would be increased if the authors could address the following questions:

1) Is cortical tension altered in mitotic Cdc42 (or Rap1)-deficient cells? The authors speculate that the fundamental reason why entosis occurs has something to do with the biophysical properties of the Cdc42-deficient mitotic cells. Changes in cortical tension would be an obvious possibility that could beapproached, including direct measurement by AFM or, potentially, inference from the angles between adjacent cell cortices at the division planes.

2) Is the frequency of entosis increased by transformation? The authors provide some evidence to suggest that this may be so, by comparing entosis frequency in tumor specimens that different in density of mitotic cells. However, the relevance of this phenomenon to cancer would be clearer if the authors could compare transformed vs. non-transformed cells.

3) Is the entosis seen in cancer cells causally linked to changes in Cdc42 and/or Rap1 signaling?

Reviewer #2:

Durgan and colleagues present data to show that mitosis drives entosis in adherent cultured cells, and that this process requires the cell cycle modulator and Rho GTPase Cdc42. This result is surprising because until now entosis had been thought to occur only in cells that have lost matrix attachment. Furthermore, the authors found that mitotic deadhesion and rounding drives entosis. Consequently, a dominant-negative form of Rap1, a small GTPase that promotes cell spreading, also drives entosis. Lastly, the authors showed that cell-in-cell structures occur in human breast tumors using a tissue array and that taxol treatment drives cell deadhesion and rounding, which promotes entosis – a previously unreported function of the drug.

While the premise of this study is quite interesting, two major issues need resolving to warrant publication.

First, the mechanism for this different mode of entosis is missing and given that this is the main point of this paper, a better understanding of what exactly drives this activity needs elucidation. How does Cdc42 effect changes in the cytoskeleton to drive de-adhesion and rounding? Is this chiefly an outcome of cells that lack cdc42, or a more general activity of cells that are rounded by being Rho-activated? If so, cells that move in Rho-dependent mechanism, such as many cancer cells could also be affected. Therefore, they need to clearly define the base mechanism for this activity.

Second, the relevance of mitotic entosis to human cancer is not clear. Is Cdc42 or mitotic entosis a prognostic indicator in cancer? The relevance of mitotic entosis to the ability of cells to metastasize, escape the immune system, or die would be useful to know, therefore data suggesting its role in cancer would make the story more exciting and compelling. The studies in established cancer cells in culture are not all that convincing, given that the dependence for this activity would not happen on glass. Using organoids made from wild type or cancer tissue would give a more convincing platform to see if mitotic entosis occurs at a higher rate in cancer. Furthermore, the data from the cores is hard to interpret and correlative. From your previous studies, it seems that mitosis can occur after entosis. Were these tumors treated with taxol? Do cancers that stratify with mitotic entosed cells have a poor or good prognosis?

Other major comments

1) What is the reason for looking at Cdc42 in the first place? Are there other cell cycle modulators that phenocopy Cdc42 depletion (in particular, any Cdc42 targets)?

2) Does Cdc42 knockdown affect cell proliferation rate?

3) Do AJs and TJs also break down in MCF7 cells?

4) To show knockdown specificity: does Cdc42 re-expression after knockdown rescue the defect in entosis? Or do siCdc42 cells that are grown longer-term and lose the knockdown display a decrease in cell-in-cell structures?

5) What downstream targets of Cdc42 might be altering the cytoskeleton?

6) Could the Rho-dependent cleavage force of cytokinesis stimulate initiation of entosis? Or does rounding in prometaphase drive it more?

7) The results shown in Figure 6 are baffling and lack proper controls. Does taxol have a pleiotropic effect on cancer cells, i.e., pro-survival by enhancing multinucleation and pro-death by enhancing cell death through entosis (and apoptosis caused by taxol itself)? Instead of showing zoomed in images of cell-in-cell structures, show zoomed out images to indicate the differences in numbers of entotic cells in control vs. drug tx. What is the degree of multinucleation with taxol? Any data in the BC tissue array to indicate taxol tx? Can you tease apart the multiple functions of taxol by co-treating cells with taxol and an entosis inhibitor, or an autophagy or lysosomal inhibitor?

8) Providing a model figure would help solidify the mechanism and take-home message.

Reviewer #3:

The authors show that:

Entosis between adherent cells is increased in cdc42-depleted cells. This novel form of entosis bears some characteristics of the one previously described in cells in suspension.

Cdc-42-dependent entosis in adherent cells is associated with and requires mitotic entry.

Cdc42 depleted cells exhibit increased mitotic rounding and deadhesion. Accordingly blockage of GTPase Rap function which affects mitotic rounding and deadhesion promotes entosis in adherent cells.

Loss of matrix-attachment is not sufficient to drive entosis in adherent cells, rather mitotic rounding is the key parameter.

Adherent cell entosis is observed in human carcinomas and cell lines and prevention of mitotic progression using taxane drugs increases entosis.

The reported data fully support the authors' conclusions. Mitotic rounding and deadhesion are essential processes associated with genome stability. Overall the reported findings are of general interest.

1) The authors show that adherent entosis requires α-catenin. Are cdc42- and α-catenin depleted cell less round or more adhesive during mitosis? Similarly, could the authors describe the shape of Rocki and cdc42 depleted cells? The role of α-catenin and Rock in adherent cell entosis should be at least discussed in the light of the novel findings of the authors.

2) The authors exclude that entosis is triggered by spindle mis-orientation since the depletion of Par-3 or aPKC lead to spindle mis-orientation without observable increase of entosis. The authors should at least report the percentage of entosis in the par-3 depletion cells.

[Editors’ note: what now follows is the decision letter after the authors submitted for further consideration.]

Thank you for submitting your article "Mitosis can drive cell cannibalism through entosis" for consideration by eLife. Your article has been favorably evaluated by Anna Akhmanova (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

While we have treated it formally as a new submission, it has been seen by the original reviews. As you can see from their comments, they appreciate that you have made substantial efforts to address the issues raised in their earlier reviews and are supportive of publication.

Essential revisions:

Reviewers 2 and 3 raise some residual issues for revision that look as if they can be addressed with minor re-writing and some re-analysis of the data. Reviewer 3 also identified some interesting potential experiments that could pursue the role of RhoA signaling, but, after consultation, we agree that these could well form the basis for a follow-up study, rather than being essential for your present manuscript.

Reviewer #1:

Overall, the authors have responded reasonably to the issues that I raised in my earlier review of their manuscript. I appreciate the analytical challenges that would be entailed by more detailed e.g. biophysical analysis of this interesting phenomenon. The experiments that they have added expand and clarify the manuscript. Therefore, I think that this is a valuable manuscript which opens up avenues for future research and support its publication in eLife.

Reviewer #2:

Durgan and colleagues present data to show that mitotic deadhesion and rounding drives entosis in adherent cultured cells upon Cdc42 depletion. This is a surprising finding because until now, entosis had been thought to occur only in cells in suspension. They also show that this process depends on cell rounding through Rho-, ROCK-, and myosin-dependent, and that dominant-negative Rap1 drives mitotic deadhesion and, consequently, entosis. Lastly, the authors showed that cell-in-cell structures are formed in cancer cell lines and patient breast tumor samples, and that taxol treatment promotes entosis both in cultured cells and in mouse xenografts – a previously unreported function of the drug.

All in all, this is a much improved manuscript and the writing is far more compelling and clearer. The authors addressed concerns about the mechanistic detail of this process sufficiently.

1) Showing that β1-integrin is necessary (subsection “Enhanced mitotic deadhesion and rounding can induce entosis: Rap1”) for entosis here is necessary, as Cdc42 has been shown previously to regulate β1-integrin.

2) For some, it may be confusing about mitotic blockers, as Cdk1 inhibitor blocks entosis and taxol promotes it. Does the Cdk1 inhibitor block mitotic deadhesion and rounding, whereas the other drugs promote it by arresting cells in mitosis?

3) Regarding the relevance of Cdc42 to cancer, could the authors comment on whether Cdc42 expression levels have been shown to impact metastases and/or patient survival? Do MCF7 and HCT116 cells perhaps express reduced levels of Cdc42, compared to normal cells (i.e. MCF10A)? Or is this just a link to cell roundedness independent of cdc42 by increased Rho activity. The answer doesn't really matter here but it just needs more clarity as to why they went from the results on rounding to cancer situations.

Reviewer #3:

The authors have addressed my comments in detail. I note that they have not demonstrated that rhoA activation is necessary for entosis in the cdc42 knock-down conditions. The authors mentioned that "Unfortunately, it is not possible to demonstrate this link unambiguously, because RhoA inhibition will block entotic cell-in-cell formation regardless of its trigger, due to downstream effects on myosin contractility (Overholtzer et al., 2007) and actin dynamics (Purvanov et al., 2014)".

Do they mean that RhoA is required in the engulfed or the engulfing cells?

Have the authors considered to address the role of RhoA dependent contractility in adherent cell entosis by:

Using a RhoA-depleted and wt mixed cell population as performed in Figure 2f-G for cdc42-depleted versus wt cells?

Analysing other regulators of the cell cortex contractility during mitosis such as ERM proteins?

https://doi.org/10.7554/eLife.27134.030

Author response

[Editors’ note: the author responses to the first round of peer review follow.]

Reviewer #1:

[…] Overall, these are interesting observations, but – though thorough – the analysis remains somewhat phenomenological. My appreciation of the (patho)biologic and/or mechanistic significance of these findings would be increased if the authors could address the following questions:

1) Is cortical tension altered in mitotic Cdc42 (or Rap1)-deficient cells? The authors speculate that the fundamental reason why entosis occurs has something to do with the biophysical properties of the Cdc42-deficient mitotic cells. Changes in cortical tension would be an obvious possibility that could beapproached, including direct measurement by AFM or, potentially, inference from the angles between adjacent cell cortices at the division planes.

We agree with the reviewer’s suggestion that cortical changes during cell division seem a likely mechanism during mitotic entosis. Although we considered measuring tension directly using AFM, we were concerned about technical issues in this particular system. Given the nature of the Cdc42 phenotype, our comparison would have to be made between control cells, which are adherent during division, and Cdc42-knockdowns, which are largely de-adhered in mitosis. Unfortunately, AFM is not readily amenable to the analysis of loosely adherent cells, which tend to slide in response to the cantilever. Given these methodological issues, we sought an alternative approach, and focussed on an analysis of molecular events at the mitotic cortex, specifically the spatiotemporal regulation of RhoA activity and actin organisation,

both of which are known to be associated with rigidity and rounding during cell division3.

These experiments were undertaken using a FRET-based biosensor to localise and monitor RhoA activity through time, and by phalloidin staining of actin in fixed cells, as shown in the new Figure 4. We find that Cdc42-depletion leads to overactivation of RhoA at the mitotic cortex, and observe a corresponding enrichment of cortical actin during metaphase, both consistent with altered rigidity. These data provide important new insight into the molecular mechanisms underlying mitotic entosis, which we have developed further with additional, inhibitor-based studies (See reviewer 2, response 1).

2) Is the frequency of entosis increased by transformation? The authors provide some evidence to suggest that this may be so, by comparing entosis frequency in tumor specimens that different in density of mitotic cells. However, the relevance of this phenomenon to cancer would be clearer if the authors could compare transformed vs. non-transformed cells.

In response to this comment, we can note that when working with immortalised, but non-transformed cell lines, such as 16HBE and MCF10A, we very rarely observe mitotic entosis under basal conditions, but instead induce this phenotype through Cdc42 depletion, Rap1 inhibition, or drug treatment. In contrast, in certain transformed cell lines, such as MCF7, Hct116 and MCAS, constitutive mitosis-induced entosis is readily detected under basal conditions, in both 2D and 3D culture. These observations are consistent with the notion that mitotic entosis may be more prevalent among transformed cells, a hypothesis that is more convincingly evidenced by our data in primary human tumour samples.

3) Is the entosis seen in cancer cells causally linked to changes in Cdc42 and/or Rap1 signaling?

Our data indicate that mitotic entosis can be induced by suppression of Cdc42 or Rap1 signalling, but also by a variety of drugs that induce prometaphase arrest and enhance mitotic rounding. In light of these data, we reason that this phenotype is unlikely to be specific to the Cdc42/Rap1 pathways, which have not been widely linked to cancer, but rather occurs more broadly in response to genetic changes and/or drug treatments that promote alterations in mitotic morphology.

Reviewer #2:

[…] While the premise of this study is quite interesting, two major issues need resolving to warrant publication.

First, the mechanism for this different mode of entosis is missing and given that this is the main point of this paper, a better understanding of what exactly drives this activity needs elucidation. How does Cdc42 effect changes in the cytoskeleton to drive de-adhesion and rounding? Is this chiefly an outcome of cells that lack cdc42, or a more general activity of cells that are rounded by being Rho-activated? If so, cells that move in Rho-dependent mechanism, such as many cancer cells could also be affected. Therefore, they need to clearly define the base mechanism for this activity.

Reviewer 2 suggests that a better understanding of the molecular mechanisms underlying mitotic entosis is required, and more specifically, an analysis of the contribution made by RhoA. To address this important point, we have undertaken a FRET-based analysis of spatiotemporal RhoA signalling, in the presence and absence of Cdc42, as outlined above (reviewer 1, response 1). These experiments indicate that loss of Cdc42 permits overactivation of cortical RhoA during mitosis, which is accompanied by an enrichment of actin at the metaphase cortex (Figure 4A-C). Building on these findings, we went on to show that the effects of Cdc42 depletion can be reverted by inhibition RhoA, or its downstream effectors, ROCK and myosin (Figure 4D-E). Together, these data develop a model in which loss of Cdc42 permits the overactivation of a RhoA/ROCK/myosin cascade, which drives enhanced mitotic deadhesion and rounding and subsequent entosis. Notably, we find that loss of adhesion during interphase is insufficient to drive entotic penetration of an adherent host cell (Figure 5). Similarly, we have found that interphase activation of myosin phosphorylation, through depletion of MYPT1, is also insufficient to drive adherent entosis (data not shown). As such, we believe this Cdc42-regulated RhoA/ROCK/myosin cascade, and its effects on entosis, are intimately linked to mitosis.

Second, the relevance of mitotic entosis to human cancer is not clear. Is Cdc42 or mitotic entosis a prognostic indicator in cancer? The relevance of mitotic entosis to the ability of cells to metastasize, escape the immune system, or die would be useful to know, therefore data suggesting its role in cancer would make the story more exciting and compelling.

These are all interesting suggestions. However, in fixed patient samples, mitotic entosis cannot be distinguished from cell-in-cell formation triggered through other mechanisms. As such, it is not possible to focus specifically on the correlation between mitotic entosis and prognosis (or metastasis, immune evasion or cell death). A more general study could be conceived, in which cell-in-cell structures, formed through any mechanism, are correlated with this broad range of cancer features. However, this would not

seem directly relevant to the current work. We draw your attention to emerging research that has explored the prognostic value of cell-in-cell formation in cancer1,2, and agree this is an area that warrants further work in the future.

The studies in established cancer cells in culture are not all that convincing, given that the dependence for this activity would not happen on glass. Using organoids made from wild type or cancer tissue would give a more convincing platform to see if mitotic entosis occurs at a higher rate in cancer.

Although we appreciate the advantages of organoid models, and have exploited them ourselves in other studies4, the issue of matrix binding somewhat complicates their use in this particular study. In most 3D-cyst based models, the central cells are matrix-deprived and therefore may be prone to undergo entosis through deadhesion, complicating our analyses. In light of this issue, we do not believe mature cysts are well suited to the study of mitotic entosis. Nevertheless, we accept the concern over cell culture on glass and have therefore analysed MCF7 breast cancer cells, cultured in 3D matrigel but imaged very early in cyst development (2-4 cell stage), at a point when all cells retain an interface with the matrix. These findings, presented in Figure 6C-D, provide evidence for mitotic entosis in 3D, as well as 2D, culture. We also draw your attention to Figure 7I-L, which demonstrates that MCF7 cells undergo increased entosis upon mitotic arrest in mouse xenografts, an in vivo 3D context. We contend that together, these data address the concern of physiological relevance.

Furthermore, the data from the cores is hard to interpret and correlative. From your previous studies, it seems that mitosis can occur after entosis. Were these tumors treated with taxol? Do cancers that stratify with mitotic entosed cells have a poor or good prognosis?

While we acknowledge that the tumour microarray data are correlative, we would argue that this is the best experiment that can currently be performed to address the occurrence of mitotic entosis in human cancer, and furthermore, that the data agree well with our more comprehensive observations in cell lines. We test our model further by manipulating mitotic index in mouse xenografts using Paclitaxel/taxol, and observe an increase in cell-in-cell formation that is also consistent with mitotic entosis among tumour cells in vivo. By combining all of these data, we believe we have built a convincing body of evidence to support the notion that mitotic entosis occurs within tumours.

The tumour microarrays used were obtained from Biomax. We have confirmed with the company that the cores come from untreated patients, so Paclitaxel/taxol is not relevant here. We do not have access to further clinical data related to these particular samples, but refer to reviewer 2, response 2 in relation to the issue of prognostics.

Other major comments

1) What is the reason for looking at Cdc42 in the first place? Are there other cell cycle modulators that phenocopy Cdc42 depletion (in particular, any Cdc42 targets)?

As outlined in the paper (see Introduction and text accompanying Figure 1), this study was initiated to investigate a possible role for Cdc42 in cell-in-cell formation among detached cells. Cdc42 is known to control epithelial junction formation, cytoskeletal organisation and myosin contractility, all of which might be expected to influence entosis, and thus it was somewhat surprising that Cdc42 depletion had very little effect on entosis among suspension cells. The observation that Cdc42 depletion could induce cell-in-cell formation among adherent cells was entirely unexpected, but provided valuable new insights, opening up the discovery of mitotic entosis.

As described in the Results, we have phenocopied loss of Cdc42 by inhibiting Rap1, a known regulator of mitotic spreading, and by modulating cell cycle progression with spindle poisons (taxol, nocodazole) and a mitotic kinesin inhibitor (STLC). All of these modulators similarly enhance mitotic deadhesion and rounding, and induce subsequent mitotic entosis.

2) Does Cdc42 knockdown affect cell proliferation rate?

As shown in Figure 3a, there is no dramatic change in cell cycle progression following Cdc42 depletion.

3) Do AJs and TJs also break down in MCF7 cells?

It is not entirely clear what the reviewer is asking here, but we assume the question relates to MCF7 junctions in the presence or absence of Cdc42? If so, we can confirm that AJs and TJs are intact in wild-type MCF7s, but less mature in Cdc42-depleted, consistent with findings in 16HBE.

4) To show knockdown specificity: does Cdc42 re-expression after knockdown rescue the defect in entosis? Or do siCdc42 cells that are grown longer-term and lose the knockdown display a decrease in cell-in-cell structures?

We consider that the use of 4 distinct and non-overlapping RNAi reagents, of different types (2 siRNA duplexes and 2 shRNA hairpins), provides sufficiently robust evidence for the specificity of this phenotype, particularly as the level of Cdc42-knockdown is shown clearly to correlate with the strength of phenotype (see siCdc42.1 v siCdc42.2; Figure 1F and accompanying text). We note that we have observed the same phenotype with an additional Cdc42-specific shRNA (data not shown) and confirm that we have never come across an si- or shRNA reagent which knocks down Cdc42, but does not give this phenotype. We contend that we have already provided adequate evidence on this point.

We have not set up an RNAi-rescue for Cdc42, because it has been reported previously that even modest overexpression of this gene itself yields phenotypic changes, confounding interpretation5.

We can confirm that prolonged passage of the cells does lead to a gradual loss of both knockdown and phenotype. However, we do not find this a very convincing proof of specificity, as this could presumably be the case regardless of whether the effect was on- or off-target.

5) What downstream targets of Cdc42 might be altering the cytoskeleton?

This is an interesting question. To address this issue, we conducted a SMARTpool-based siRNA screen of Rho-family effectors, assaying for the induction of adherent entosis.

Although this screen yielded 3 preliminary hits, none were robustly validated through follow up work with additional siRNAs, and therefore seem likely to have been off-target. Our inability to identify a single Cdc42 target may be a limitation of the library used, as we cannot be sure that all SMARTpools work efficiently, or may perhaps indicate redundancy, as some of the targets are grouped into families (e.g. PAKs 1-3 and 4-6). More interestingly, as mitotic entosis is a multi-step process, it may represent a more complex phenotype in which multiple hits are required simultaneously. Although interesting, we feel that further analysis of this point would go beyond the scope of this paper.

6) Could the Rho-dependent cleavage force of cytokinesis stimulate initiation of entosis? Or does rounding in prometaphase drive it more?

This is an interesting point, and our new data (Figure 4) certainly implicate RhoA activity in both mitotic rounding and entosis. Based on timelapse imaging, we have observed cell-in-cell formation occurring at various stages of mitosis. In some cases, and of course particularly upon taxol/nocodazole/STLC treatment, entosis occurs during prometaphase. In other cases, one or both daughters are internalised during/shortly after cytokinesis. While the general biophysical changes associated with mitosis are clearly important for adherent entosis, we have not found evidence of an obvious link with one particular phase of mitosis compared to another.

7) The results shown in Figure 6 are baffling and lack proper controls.

It is not clear exactly what the reviewer finds confusing, or what controls they consider to be lacking? The rationale for this experiment was to test the model of mitotic entosis in cell lines and in vivo, by manipulating mitotic index with drugs, and then assessing the effect on cell- in-cell formation. We clearly demonstrate that taxol, nocodazole and STLC all increase mitotic index and induce a corresponding increase entosis, consistent with the process of mitotic entosis. Furthermore, these studies reveal that these drugs also significantly enhance mitotic deadhesion and rounding, providing independent support for a link between mitotic morphology changes and cell-in-cell formation. We feel these experiments are well designed and the data clear. These findings are also important with respect to identifying a novel activity of the commonly used chemotherapeutic drug Paclitaxel.

Does taxol have a pleiotropic effect on cancer cells, i.e., pro-survival by enhancing multinucleation and pro-death by enhancing cell death through entosis (and apoptosis caused by taxol itself)?

As our goal was to assay for the occurrence of mitotic entosis, our Paclitaxel/taxol experiments were timed accordingly to optimise this, with samples analysed at 24hrs post- treatment in both cell culture and mice. At this early timepoint, the occurrence of mitotic entosis is readily detectable, but there is little opportunity to analyse subsequent effects on cancer cell survival or death. Conceptually, it seems unlikely that multinucleation would be observed in the context of taxol, as the host cell would be prone to arrest in prometaphase too. However, we would expect the effects of taxol to be pleiotropic, as this drug is well known to cause multi-polar division and cell death, as well as prometaphase arrest6.

Through our work, we can now add mitotic rounding and cell cannibalism to the list of effects Paclitaxel/taxol can induce, which we believe will be a useful new insight to share with the field.

Instead of showing zoomed in images of cell-in-cell structures, show zoomed out images to indicate the differences in numbers of entotic cells in control vs. drug tx.

A zoomed in image is presented in Figure 7L to demonstrate the appearance of a typical cell-in-cell structure within a xenograft sample, as clearly as possible. A zoomed out image would not be particularly helpful in this case, as these structures will not be readily distinguishable (unlike mitotic cells, which are easy to recognise as bright pHH3+ve spots, even at low resolution, Figure 7I). Given this, the bar graph presented in Figure 7L, which indicates scoring from multiple slices across multiple xenografts, provides much more meaningful quantitative data than a single image.

What is the degree of multinucleation with taxol?

The timing of our experiment is not compatible with this analysis. However, the expectation would be that since taxol causes mitotic arrest, multinucleation is an unlikely outcome.

Any data in the BC tissue array to indicate taxol tx?

According to Biomax, the company who supplied the TMA, the patients are all untreated.

Can you tease apart the multiple functions of taxol by co-treating cells with taxol and an entosis inhibitor, or an autophagy or lysosomal inhibitor?

We have not attempted to explore whether mitotic entosis makes a functional impact on taxol treatment. We feel the suggested experiments go beyond the scope of this study and would not be specific enough to draw strong conclusions. The only inhibitor that has been used to block entosis in vivo is Y-27632. This drug will block all functions of ROCK (and PKN), and thus cannot be used to implicate entosis specifically. With regards to autophagy and lysosomal inhibitors, we assume the reviewer is thinking of a method with which to manipulate entotic corpse degradation? However, these drugs will also have a range of other effects and, again, cannot be used to dissect the effects of entosis specifically.

8) Providing a model figure would help solidify the mechanism and take-home message.

Thanks for this suggestion, we have added a new Figure 8 to clarify our main conclusions.

Reviewer #3:

[…] 1) The authors show that adherent entosis requires α-catenin. Are cdc42- and α-catenin depleted cell less round or more adhesive during mitosis? Similarly, could the authors describe the shape of Rocki and cdc42 depleted cells? The role of α-catenin and Rock in adherent cell entosis should be at least discussed in the light of the novel findings of the authors.

These are interesting suggestions, and analysis of ROCK in particular has proven important for our work; the data are included in the new Figure 4D-E. As noted above (reviewer 2, response 1), we find that inhibition of ROCK (Y-27632), RhoA (C3) or myosin (Blebbistatin), reverts the retraction phenotype induced by Cdc42-depletion during mitosis. Combined with our FRET-based analysis of RhoA activity, these data suggest that Cdc42 constrains the cortical activation of RhoA during epithelial cell mitosis. Loss of Cdc42 permits overactivation of a RhoA/ROCK/myosin cascade, which can drive mitotic rounding and entosis.

With regards to α-catenin, we have not observed an obvious difference in mitotic morphology between cells depleted of Cdc42 alone and those co-depleted of both Cdc42 and a-catenin; all show reduced spreading and increased rounding. We assume that the defect in adherent entosis observed upon a-catenin depletion is instead related to the cells’ inability to form the cell-cell contacts which initiate subsequent internalisation.

2) The authors exclude that entosis is triggered by spindle mis-orientation since the depletion of Par-3 or aPKC lead to spindle mis-orientation without observable increase of entosis. The authors should at least report the percentage of entosis in the par-3 depletion cells.

In the original text, we had depleted Par6B (not Par3) and aPKC to explore the possible role of the Cdc42-dependent polarity complex during mitotic entosis. As noted by the reviewer, loss of Par6B/aPKC did not phenocopy Cdc42-depletion in this context, even though these proteins so often function together. This finding helps to exclude certain mechanisms as being sufficient to trigger mitotic entosis, such as disruption of junction formation, spindle orientation or control of the metaphase cortex.

We take the point that this data set was not reported thoroughly in our previous draft and have focussed on aPKC here to provide more comprehensive and quantitative findings. In the new Figure 3—figure supplement 1, we first verify aPKC knockdown, using a duplex that codepletes aPKCɩ and aPKCζ and an antibody that recognises both isoforms. We then quantify the associated defect in junction formation, to confirm a functional loss of the protein(s), and as requested, show graphically that there is no detectable entosis observed among aPKC-depleted cells under adherent conditions, across multiple independent experiments.

Our data suggest that defects in aPKC-dependent phenotypes, such as junction formation and spindle orientation, are not sufficient to drive mitotic entosis. However, we do note that we cannot completely exclude the possibility that aPKC may play some role during mitotic entosis. It remains formally possible that a stronger knockdown/knockout, or codepletion with another pathway, may manifest an effect. Thus, to be cautious, we use these data to exclude certain cellular mechanisms, rather than the aPKC gene itself.

References

1) Schwegler, M. et al. Prognostic Value of Homotypic Cell Internalization by Nonprofessional Phagocytic Cancer Cells. Biomed Res Int 2015, 359392–14 (2015).

2) Schenker, H., Büttner-Herold, M., Fietkau, R. & Distel, L. V. Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas. Radiat Oncol 12, 21 (2017).

3) Matthews, H. K. et al. Changes in Ect2 localization couple actomyosin-dependent cell shape changes to mitotic progression. Dev. Cell 23, 371–383 (2012).

4) Durgan, J., Kaji, N., Jin, D. & Hall, A. Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis. J. Biol. Chem. 286, 12461–12474 (2011).

5) Wallace, S. W., Durgan, J., Jin, D. & Hall, A. Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B. Mol. Biol. Cell 21, 2996–3006 (2010).

6) Zasadil, L. M. et al. Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med 6, 229ra43–229ra43 (2014).

[Editors' note: the author responses to the re-review follow.]

Reviewer #2:

[…] 1) Showing that β1-integrin is necessary (subsection “Enhanced mitotic deadhesion and rounding can induce entosis: Rap1”) for entosis here is necessary, as Cdc42 has been shown previously to regulate β1-integrin.

Thank you for highlighting this omission. Our data indicate that loss of b1-integrin is insufficient to induce entosis among adherent cells and we have included a new Supplementary Figure (Figure 5—figure supplement 1) to show this, accompanied by text in the subsection “Enhanced mitotic deadhesion and rounding can induce entosis: Rap1”.

Please note: we assume that there was a typo in the reviewer 2, point 1 text, as we had previously indicated (and now show) that b1-integrin is unnecessary, rather than necessary, for entosis under these conditions.

2) For some, it may be confusing about mitotic blockers, as Cdk1 inhibitor blocks entosis and taxol promotes it. Does the Cdk1 inhibitor block mitotic deadhesion and rounding, whereas the other drugs promote it by arresting cells in mitosis?

Thank you for drawing our attention to this potential for confusion. We believe the key difference between Cdk1i versus taxol/nocodazole/STLC in this context lies with the timing of cell cycle arrest. Cdk1 inhibition arrests cells at the G2/M transition, thereby inhibiting mitotic deadhesion and rounding as well as consequent entosis. Taxol, nocodazole and STLC, on the other hand, arrest cells in prometaphase, during which they do deadhere and round; indeed all 3 of these drugs actually enhance these morphological changes. Consistent with our model of mitotic entosis, these drugs also promote associated cell-in-cell formation. We have added text to clarify the difference between these drug induced effects in the subsection “Taxane treatment promotes mitosis-induced entosis”.

3) Regarding the relevance of Cdc42 to cancer, could the authors comment on whether Cdc42 expression levels have been shown to impact metastases and/or patient survival? Do MCF7 and HCT116 cells perhaps express reduced levels of Cdc42, compared to normal cells (i.e. MCF10A)? Or is this just a link to cell roundedness independent of cdc42 by increased Rho activity. The answer doesn't really matter here but it just needs more clarity as to why they went from the results on rounding to cancer situations.

This is an interesting point. Although it is tempting to speculate that Cdc42 deregulation could be directly involved in tumour cell cannibalism, this specific GTPase has not been widely implicated in cancer and so we have not tested for this directly. We would consider it more likely that there are multiple pathways that can enhance mitotic cell rounding to drive entosis, perhaps converging on activation of RhoA, ROCK and myosin.

Our rationale for exploring cancer cell lines was that a) cancer cells tend to undergo deregulated divisions, and b) mitotic rounding has emerged as a process that may be relevant in cancer biology (e.g. Cadart et al., 2014). We have attempted to outline this reasoning more clearly in the subsection “Mitosis-induced entosis occurs constitutively in adherent cancer cell lines and human 258 tumours with pleiotropic effects”.

Reviewer #3:

The authors have addressed my comments in detail. I note that they have not demonstrated that rhoA activation is necessary for entosis in the cdc42 knock-down conditions. The authors mentioned that "Unfortunately, it is not possible to demonstrate this link unambiguously, because RhoA inhibition will block entotic cell-in-cell formation regardless of its trigger, due to downstream effects on myosin contractility (Overholtzer et al., 2007) and actin dynamics (Purvanov et al., 2014)".

Do they mean that RhoA is required in the engulfed or the engulfing cells?

In the context of detachment-induced entosis, it is well established that RhoA activity in the internalising cell promotes contractility and stiffening through ROCK and myosin, to facilitate the ‘invasion’ of a more physically deformable host1,2. Our data suggest a similar pathway operates during mitotic entosis, which is also dependent on ROCK activation and similarly involves localised myosin phosphorylation the internalising cell tail.

Have the authors considered to address the role of RhoA dependent contractility in adherent cell entosis by:

Using a RhoA-depleted and wt mixed cell population as performed in Figure 2f-G for cdc42-depleted versus wt cells?

Analysing other regulators of the cell cortex contractility during mitosis such as ERM proteins?

We agree that these are interesting questions that, as noted by the editor, could form the basis of follow up work.

References

1) Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966–979 (2007).

2) Sun, Q. et al. Competition between human cells by entosis. Cell Res. 24, 1299–1310 (2014).

https://doi.org/10.7554/eLife.27134.031

Article and author information

Author details

  1. Joanne Durgan

    1. The Babraham Institute, Cambridge, United Kingdom
    2. Memorial Sloan Kettering Cancer Center, New York, United States
    Contribution
    JD, Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing
    Competing interests
    The authors declare that no competing interests exist.
  2. Yun-Yu Tseng

    1. Memorial Sloan Kettering Cancer Center, New York, United States
    2. Weill Graduate School of Medical Sciences, Cornell University, New York, United States
    Contribution
    Y-YT, Resources
    Competing interests
    The authors declare that no competing interests exist.
  3. Jens C Hamann

    1. Memorial Sloan Kettering Cancer Center, New York, United States
    2. Louis V Gerstner Jr Graduate School of Biomedical Sciences, New York, United States
    Contribution
    JCH, Investigation
    Competing interests
    The authors declare that no competing interests exist.
  4. Marie-Charlotte Domart

    The Francis Crick Institute, London, United Kingdom
    Contribution
    M-CD, Resources, Investigation
    Competing interests
    The authors declare that no competing interests exist.
  5. Lucy Collinson

    The Francis Crick Institute, London, United Kingdom
    Contribution
    LC, Resources, Funding acquisition, Investigation
    Competing interests
    The authors declare that no competing interests exist.
  6. Alan Hall

    Memorial Sloan Kettering Cancer Center, New York, United States
    Contribution
    AH, Resources, Supervision
    Competing interests
    The authors declare that no competing interests exist.
  7. Michael Overholtzer

    Memorial Sloan Kettering Cancer Center, New York, United States
    Contribution
    MO, Resources, Funding acquisition
    Competing interests
    The authors declare that no competing interests exist.
  8. Oliver Florey

    The Babraham Institute, Cambridge, United Kingdom
    Contribution
    OF, Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing
    For correspondence
    oliver.florey@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon 0000-0002-1075-7424

Funding

Cancer Research UK (CA47718/A16337)

  • Joanne Durgan
  • Oliver Florey

Revson Senior Fellowship

  • Joanne Durgan

Marie-Curie Fellowship (624161)

  • Joanne Durgan

L'Oreal & UNESCO UK and Ireland

  • Joanne Durgan

National Cancer Institute (RO1CA154649)

  • Jens C Hamann
  • Michael Overholtzer

Cancer Research UK (MR/K01580X/1)

  • Marie-Charlotte Domart
  • Lucy Collinson

Medical Research Council (MR/K01580X/1)

  • Marie-Charlotte Domart
  • Lucy Collinson

Wellcome (MR/K01580X/1)

  • Marie-Charlotte Domart
  • Lucy Collinson

Biotechnology and Biological Sciences Research Council (MR/K01580X/1)

  • Marie-Charlotte Domart
  • Lucy Collinson

Engineering and Physical Sciences Research Council (MR/K01580X/1)

  • Marie-Charlotte Domart
  • Lucy Collinson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank the Babraham Institute Imaging and FACS facilities for technical assistance, Dan Jin for reagents, Adrian Saurin and Nick Ktistakis for helpful comments and Len Stephens for his support. We acknowledge Elisa De Stanchina for xenograft injections at the Antitumor Assessment Core Facility at MSKCC. JD was funded by a Revson Senior Fellowship in the Biomedical Sciences, a Marie-Curie Fellowship (624161) and a L’Oreal for Women in Science UK award, LC by Cancer Research-UK, the MRC, Wellcome Trust, BBSRC and EPSRC (MR/K01580X/1), MO by the National Cancer Institute (RO1CA154649), and OF by a Cancer Research-UK fellowship (CA47718/A16337); we also acknowledge the friends and family of Jean Florey, who donated in her memory. We dedicate this work to our friend and colleague Alan Hall, who so sadly passed away prior to its publication.

Ethics

Animal experimentation: Xenograft transplantation studies were performed in full compliance with NIH guidelines and approved with Institutional Animal Care and Use Committee (IACUC) guidelines at Memorial Sloan-Kettering Cancer Center under the approved protocol 04-03-009. Xenograft injections were performed by Elisa De Stanchina at the Antitumor Assessment Core Facility at MSKCC.

Reviewing Editor

  1. Alpha Yap, Reviewing Editor, The University of Queensland, Australia

Publication history

  1. Received: March 23, 2017
  2. Accepted: June 13, 2017
  3. Version of Record published: July 11, 2017 (version 1)
  4. Version of Record updated: July 11, 2017 (version 2)

Copyright

© 2017, Durgan et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,591
    Page views
  • 609
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Comments

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading